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  Summary 
Summary 
 
GABAergic interneurons are the main source of inhibition in the central nervous 
system. In addition they play a crucial role during development since in a paradoxical 
fashion they are the origin of the first excitatory signals in the immature brain. 
GABAergic interneurons comprise about 10 – 20% of the neuronal cell population 
and they can be divided into several subtypes. GABAergic interneuron classifications 
have been based on different criteria, including anatomical, neurochemical or 
physiological characteristics. Although the overall number of interneurons is small 
compared to that of principal cells, by virtue of their connectivity, interneurons are 
able to shape and regulate the activity of numerous principal cells and thus influence 
network activity.  
To elucidate the role of interneurons during development and in the mature brain 
specific modifications of their molecular and physiological properties are required and 
can be achieved by selective ablation of distinct genes. An established and widely 
used technique is that of the CRE/loxP system. For ablation of a desired gene in a 
cell-type specific fashion the generation of mice expressing CRE recombinase in a 
subset of cells plus the generation of mice with a floxed allele are a prerequisite. 
The aim of this study was the generation of mice with CRE expression in all 
GABAergic interneurons and of mice with restricted expression of CRE recombinase 
in a subset of GABAergic interneurons, the somatostatin-positive interneurons. To 
this end mice with CRE expression under the control of the GAD67 promoter 
(GAD67CRE/+) - a common feature of almost all interneurons - and mice with CRE 
recombinase expression under the control of the somatostatin promoter (SOMCRE/+) 
were generated. Immunohistochemical analysis of both GAD67CRE/+ and SOMCRE/+ 
mice provided evidence that CRE recombinase is functional in vivo. Co-localisation 
studies of CRE recombinase and endogenous GAD67 expression, demonstrated a 
100% overlap. Double-labelling experiments of endogenous somatostatin and CRE 
recombinase demonstrated a good correspondence in the hippocampus but less so 
in other brain regions. No developmental or behavioural deficits were observed as a 
consequence of the genetic manipulations. Cell-type specific ablations of several 
genes of interest, e.g. trkB receptors in GABAergic interneurons, NR1 and GluR-A 
subunits in somatostatin-positive interneurons are currently being generated and will 
help provide more insights into the function of GABAergic interneurons during 
development and their involvement in specific network activity. 
  Zusammenfassung 
Zusammenfassung 
 
GABAerge Interneurone stellen die Hauptquelle für Inhibition im zentralen 
Nervensystem dar. Sie spielen außerdem eine wichtige Rolle während der 
Entwicklung, da sie paradoxerweise im embryonalen Gehirn Ursprung der ersten 
exzitatorischen Signale sind.  
GABAerge Interneurone umfassen 10 bis 20% der neuronalen Zellpopulation und 
können in verschiedene Subpopulationen eingeteilt werden. Die Klassifizierung von 
Interneuronen basiert auf der Einteilung nach anatomischen, neurochemischen und 
physiologischen Kriterien. Obwohl Interneurone eine vergleichsweise kleine Gruppe 
darstellen, haben sie auf Grund ihrer Verschaltung einen sehr großen modulierenden 
Einfluss auf Netzwerkaktivitäten indem sie die Erregbarkeit vieler Prinzipalzellen 
verändern. 
Um mehr über die Rolle von Interneuronen im sich entwickelnden und im adulten 
Gehirn zu erfahren sind gezielte Veränderungen ihrer molekularen und 
physiologischen Eigenschaften notwendig. Diese Modifizierungen können durch 
selektives Abschalten einzelner Gene erreicht werden.  
Eine etablierte Methode, um spezifisch Gene in bestimmten Zellpopulationen 
abzuschalten, ist das CRE/loxP System. Dieses System basiert auf der Kombination 
zweier transgener Mauslinien wovon eine CRE Rekombinase zelltypspezifisch 
exprimiert und die andere ein gefloxtes Allel besitzt. 
Das Ziel dieser Studie war es zwei transgene Mäuse zu generieren, die CRE 
Rekombinase jeweils spezifisch unter der Kontrolle eines interneuronalen Promoters 
exprimieren: zum einen wurde der GAD67 Promoter verwendet, der ein 
gemeinsames Merkmal aller Interneurone darstellt (GAD67CRE/+- Maus) und zum 
anderen der Promoter des Somatostatin Gens, der spezifisch für eine bestimmte 
interneuronale Subpopulation ist (SOMCRE/+- Maus). Die immunhistochemische 
Analyse beider Mäuse bestätigte die Funktionalität der CRE Rekombinase in vivo. 
Zusätzlich wurde mit Kolokalisationexperimenten überprüft, ob die Expression der 
CRE Rekombinase mit der des endogenen Gens, dessen Promoter verwendet 
wurde, übereinstimmt. Dies ergab im Fall der GAD67CRE/+- Maus eine 100% 
Übereinstimmung. SOMCRE/+- Mäuse wiesen eine gute Übereinstimmung im 
Hippocampus auf, jedoch nicht in kortikalen Gehirnregionen. Bei beiden Mäusen 
konnten keine entwicklungs- oder verhaltensspezifischen Auffälligkeiten auf Grund 
der genetischen Manipulationen festgestellt werden. 
Verpaarungen der GAD67CRE/+- und der SOMCRE/+- Mäuse mit transgenen Mäusen, 
die ein gefloxtes Gen besitzen, werden zurzeit durchgeführt. Dadurch sollen unter 
anderem der trkB Rezeptor in GABAergen Interneuronen, sowie die NR1 und GluR-A 
Untereinheiten von NMDA- und AMPA Rezeptoren in Somatostatin positiven 
Interneuronen abgeschaltet werden. Die Analyse dieser zelltypspezifischen Knock-
out Mäuse wird dazu beitragen die Funktion von GABAergen Interneuronen in 
Entwicklungs- und Netzwerkprozessen weiter aufzuklären. 
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  1. Introduction 
1. Introduction 
 
The main functions of the mammalian nervous system are the integration of all 
external and internal afferent stimuli as well as the coordination and regulation of all 
processes of an organism. To fulfil these tasks, the basic units of the central nervous 
system, the neurons, are highly connected and build complex networks. These 
networks are based on a balance between two main groups of neurons that exhibit 
excitation and inhibition, respectively. Excitatory cells, often also referred to as 
principal cells constitute the majority of neurons in the brain. They use glutamate as a 
neurotransmitter. Inhibition is mediated by interneurons which represent 25% of all 
neurons in the neocortex and around 10% in the hippocampus (Aika Y et al., 
1994;Woodson W et al., 1989;DeFelipe, 1993). Despite their small number, 
interneurons regulate and shape the activity of principal cells and thereby play an 
important role in network activity. Concerning their anatomical, physiological and 
molecular properties, principal cells form a homogenous group. On the other hand, 
interneurons are more heterogeneous and can be divided into several subgroups 
which cannot be clearly delimited from each other’s. Still, they share some functional 
features that distinguish them from principal cells. First, almost all contain γ-
aminobutyric acid (GABA) (Houser CR et al., 1983) as the primary inhibitory 
transmitter instead of glutamate (Baughman and Gilbert, 1981) and second, most 
interneurons have aspiny dendrites. However, regarding their morphological, 
molecular and electrophysiological properties GABAergic interneurons are quite 
diverse and in fact based on these criteria they can be divided in several subgroups. 
The following chapters describe these variations in more detail and refer exclusively 
to the interneurons of the hippocampus. 
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1.1. The hippocampus 
 
 
 
Fig. 1 Anatomical structure of the hippocampus. A: Drawing of the neural circuitry of a rodent 
hippocampus by S. Ramón y Cajal (Ramon y Cajal S., 1911). B: Nissl-stained section 
(coronal) of the hippocampus of an adult mouse. s. o.: Stratum oriens; s. p.: Stratum 
pyramidale; s. r.: Stratum radiatum; s. lm.: Stratum lacunosum-moleculare; h: Hilus; DG: 
Denate gyrus; GC: Granule cell layer. Scale bar: 250 µm. 
 
The hippocampal formation is a structure located in the medial temporal lobe and 
belongs to the limbic system. Its shape resembles that of a sea horse which is 
reflected in the Greek name (hippo = horse, kampos = sea monster). The 
hippocampal formation consists of three distinct areas: the dentate gyrus, the cornu 
ammonis fields CA1 to CA3 and the subiculum (Fig. 1). The hippocampus proper 
(dentate gyrus and CA1 - CA3) is a highly laminar structure. The dentate gyrus is 
formed by the granule cell layer, which is the principal cell layer, the molecular layer 
above and the polymorphic zone (hilus) below. The CA1 - CA3 field is build of the 
stratum oriens followed by stratum pyramidale (principal cell layer), stratum radiatum 
and stratum lacunosum-moleculare (Lorente de No R., 1934;Ramon y Cajal S., 
1893). The main excitatory pathway of the hippocampus is the so called trisynaptic 
circuit (Fig. 2) (Andersen et al., 1971;Ramon y Cajal S., 1911). The granule cells of 
the dentate gyrus are the first step in that loop. They receive input via the perforant 
path from layer II of the entorhinal cortex. The mossy fibers (granule cell axon 
bundle) project to the principal cell dendrites of the CA3 region where the information 
is further conveyed to the CA1 principal cells via the Schaffer collaterals (Schaffer K., 
1892). CA1 principal cells represent the major output region of the hippocampus and 
they send their projections to the subiculum and back to the deep layers of the 
entorhinal cortex. From the entorhinal cortex the information is further projected to 
different cortical areas including the one from where the information originated. 
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Fig. 2 Scheme of the trisynaptic circuit of the hippocampus. The major excitatory 
connections are shown: Granule cells receive input from the entorhinal cortex via the 
perforant path and send it via the mossy fibers to CA3 pyramidal cells which in turn mediate 
the input to CA1 pyramidal cells via the Schaffer collaterals. Figure (modified) from (Purves 
et al., 2001) 
 
 
1.2. Classification of the different interneuronal subtypes of the 
hippocampus 
 
Different attempts were made to divide the different interneuronal types into specific 
subgroups. Classifications were performed based on anatomical, neurochemical or 
physiological criteria. But there was increasing evidence that there was not always a 
direct correspondence when the above-mentioned classification criteria were applied. 
Thus, an anatomically homogenous class of interneurons may give rise to several 
subgroups if neurochemical or physiological parameters are also applied. However, 
keeping in mind that there are always some exceptions regarding the classification of 
interneuronal subpopulations, it still is useful to subdivide interneurons into several 
groups. 
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1.2.1. Anatomical features of interneurons and the functional implications 
 
GABAergic cells are also referred to as local-circuit interneurons since most often 
their comparatively short axons regulate the excitability of nearby principal cells. This 
contrasts with the axonal pattern of many principal cells that frequently project to 
distant brain regions. However, there are exceptions also to this rule and GABAergic 
interneurons with long projecting axons have been described. Retrograde tracing 
studies identified interneurons in the hilus that participate in the commissural 
pathway of the hippocampus (Seress L and Ribak CE, 1983;Ribak et al., 1986) and 
long-range GABAergic interneurons of the hippocamposeptal pathway (Alonso A and 
Köhler C, 1982). The latter are neurons in stratum oriens and stratum pyramidale of 
the CA3 region and the hilus that target interneurons in the medial septum (Rose and 
Schubert, 1977). 
 
 
 
Fig. 3 Afferences of GABAergic interneurons on pyramidal cells. The coloured circles 
represent different interneuronal subtypes and the corresponding lines mark the domain of 
the pyramidal cell that gets innervated. Below each interneuronal subtype, the neurochemical 
content is indicated. Figure from (Danglot et al., 2004). 
 
Since structure and function are closely linked, the morphology of interneurons 
provides important information about their role in neuronal networks. The laminar 
distribution of the axonal arborization of an interneuron demonstrates the locations of 
its postsynaptic target domains on the principal cell (Fig. 3). The three major types of 
interneurons in the hippocampus are axo-axonic (chandelier) (Kosaka, 
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1983;Somogyi P et al., 1985;Somogyi, 1977), basket and stratum oriens-lacunosum-
moleculare (O-LM) cells (Lorente de No R., 1934;Ramon y Cajal S., 1893). The 
somata of axo-axonic cells are located in or near the principal cell layer and the 
dendritic tree spans all layers whereas the axon terminates in the principal cell layer 
and innervates the axon initial segment of principal cells (Kosaka, 1983). The group 
of basket cells is more heterogenous and named after the basket-like structure that 
their axons form around principal cell somata. This structure arises from convergent 
innervation of multiple basket cells, that preferentially synapse onto the somata and 
proximal dendrites of principal cells (Gulyás AI et al., 1993). Axons of O-LM cells, in 
contrast, target to distal dendrites of principal cells in stratum lacunosum-moleculare 
whereas their dendrites arborise either horizontally in stratum oriens (CA1) or span 
all layers except stratum lacunosum-moleculare (CA3). There are, however, some  
O-LM cells that exhibit long-distance projections to the medial septum (Toth et al., 
1993). 
In fact, the defined targeting of cellular compartments directly translates into 
differential functional effects of postsynaptic electrogenesis. For example, synapses 
of basket or axo-axonic cells terminate on the perisomatic region of principal cells. 
Hence, inhibition mediated by these cells will suppress repetitive generation of 
sodium-dependent action potentials and thereby directly control the output of 
principal cells. Synapses of O-LM cells on the other hand, target principal cell 
dendrites and will suppress calcium-dependent action potentials thus modulating the 
input from other cells (Miles et al., 1996).  
Of particular note are GABAergic interneurons that appear to be interneuron 
selective. Anatomical studies of Ascády et al. and Gulyás et al. identified three 
different types of interneuron-selective inhibitory cells (IS-1, -2, -3) based on their 
connectivity and expression of neurochemical markers (Acsady et al., 1996b;Acsady 
et al., 1996a;Gulyas et al., 1996;Hajos N et al., 1996).  
Another hallmark of interneuron connectivity is the presence of gap junctions that 
underlie the electrical coupling between GABAergic interneuronal subtypes. In most 
studies however it has been convincingly demonstrated that gap junction coupling of 
interneurons occurs by and large between interneurons of the same subtype 
(Venance et al., 2000), although exceptions to this rule have also been reported (Dr. 
A. Caputi, personal communication). Functional studies at the network level provided 
evidence that gap junction coupling stabilises robust synchronous rhythmic activity of 
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defined frequencies (gamma) in the hippocampus (Hormuzdi et al., 2001;Buhl et al., 
2003). 
 
1.2.2. Distinction of interneurons according to their neurochemical content and 
functional implications 
 
The most obvious common characteristic of GABAergic interneurons is the use of 
GABA as the only neurotransmitter (Storm-Mathisen et al., 1983), although co-
release of GABA with other transmitters has also been reported in several systems 
such as retina (Huang S. and Moody S.A., 1998) and spinal cord (Jonas et al., 1998). 
Additionally, it has been reported that a small group of interneurons expresses 
glycine (Danglot et al., 2004) as an inhibitory transmitter as well as another group 
that expresses acetylcholine (Frotscher M et al., 1986). Furthermore, GABAergic 
interneurons also co-express the GABA synthesizing enzymes glutamic acid 
decarboxylase 65 (GAD65) and glutamic acid decarboxylase 67 (GAD67) (Ribak, 
1978) that seem to subserve different roles which are not completely clarified so far. 
After the identification of GABA as the main inhibitory transmitter in the forebrain, the 
almost exclusive presence of certain calcium-binding proteins and neuropeptides in 
GABAergic interneurons was reported in numerous studies (Fig. 3) (Celio, 
1986;Kosaka et al., 1987;Baimbridge and Miller, 1982) (Jacobowitz DM and Winsky 
L, 1991). In fact, these proteins were frequently used particularly in anatomical 
studies to characterise and classify GABAergic interneuron subtypes. The most 
common neurochemical markers that have been extensively used are neuropeptides 
such as somatostatin (SOM) or cholecystokinin (CCK) and the calcium-binding 
proteins parvalbumin (PV), calbindin (CB) and calretinin (CR). 
Dependent on the subregion of the hippocampus, PV-expressing interneurons 
constitute a large fraction of GABAergic interneurons that is about 20 to 29% (Freund 
and Buzsaki G, 1996;Jacobowitz DM and Winsky L, 1991). The GABA content in this 
cell population is low compared to that of other interneurons. This may be due to the 
high spontaneous firing rate of PV-positive interneurons leading to extensive 
transmitter release (Aika Y et al., 1994;Kosaka et al., 1987). PV-positive interneurons 
subserve perisomatic inhibition of principal cells and GABAergic interneurons and 
can be classified into basket and axo-axonic cells (Katsumaru H., 1988). It should be 
pointed out however, that some basket cells express the neuropeptides CCK or VIP 
rather than PV (Acsady et al., 1996b;Gulyás AI et al., 1991).  
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In contrast to the selective expression of PV in a subgroup of GABAergic 
interneurons, the expression of the calcium-binding protein CB is somewhat less 
specific. In addition to its presence in certain GABAergic interneurons it is also 
present in hippocampal principal cells such as granule cells of the dentate gyrus and 
some pyramidal cells of the CA1 region (Baimbridge and Miller, 1982). CB-
expressing interneurons in the hippocampus constitute 10 -12% of all GABAergic 
cells and they preferentially innervate principal cell dendrites.  
Another major calcium-binding protein is CR (Jacobowitz DM and Winsky L, 1991). If 
additional morphological features are taken into account, CR-positive interneurons 
can be further subdivided into spiny neurons that innervate dendrites of principal cells 
and aspiny neurons that innervate other GABAergic interneurons. 
In addition to being useful interneuronal marker for anatomical studies, the functional 
role of calcium-binding proteins has been demonstrated by several 
electrophysiological studies (Blatow et al., 2003;Rozov et al., 2001;Katz and Miledi, 
1968;Caillard et al., 2000;Neher, 1998). They bind calcium ions in the pre-synaptic 
terminal and hence modulate action potential dependent vesicular transmitter 
release. The kinetics of calcium binding and release from these cellular calcium 
buffers - slow kinetics for PV and fast for CB and CR - differentially effect transmitter 
release and hence short-term modifications such as facilitation and depression 
(Burnashev and Rozov, 2005). 
The major neuropeptides subserving as neurochemical markers of GABAergic 
subclasses are cholecystokinin (CCK), vasoactive intestinal peptide (VIP), 
neuropeptideY (NPY) and somatostatin (SOM) which are either co-released with 
GABA or serve as modulators of GABA release. SOM, being important for the study 
described later, is expressed in a large number of GABAergic cells (12.5 – 16%) 
across all subregions of the hippocampus (Kosaka T. et al., 1988).  
 
1.2.3. Electrophysiological characteristics of interneurons 
 
GABAergic interneurons can be characterised based on their firing pattern and the 
shape of their action potentials that differ from that of principal cells. Upon current 
injection the latter exhibit either a regular spiking or an intrinsically bursting pattern 
that is often associated with accommodation during sustained stimulation (Madison 
and Nicoll, 1984;Stafstrom et al., 1984). In contrast, interneurons exhibit a variety of 
firing patterns and action potential characteristics. The molecular basis underlying 
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specific firing patterns of interneurons is the differential expression of voltage-gated 
ion channels (Zhang and McBain, 1995b;Zhang and McBain, 1995a). For instance, 
fast-spiking PV-positive cells, express Kv3 channels that possess certain properties 
such as fast deactivation, high activation threshold and lack of inactivation. These 
characteristics are crucial for the typical fast (up to 200 Hz), non-accommodating, 
non-attenuating spiking pattern (Baranauskas et al., 2003;Du et al., 1996). Most 
hippocampal CB-positive interneurons fire at lower frequency and the irregular 
spiking pattern is further characterised by a long interval between the initial action 
potential burst followed by more regular action potential spiking (Fuchs et al., 2007). 
O-LM cells on the other hand – that are mainly SOM-expressing – can be identified 
by a ‘sag’ (H-current) in response to hyperpolarizing current injection (McCormick 
and Pape, 1990;Sik et al., 1994;McBain et al., 1994) and depolarising current 
injection results in a regular train of action potentials that decrease in amplitude and 
slightly also in frequency.  
GABAergic interneurons differ from principal cells also in respect to their excitability 
(McCormick et al., 1985) and the expression of ligand-gated ion channels. Thus, 
there is a vast body of literature showing the differential subunit expression of several 
receptors (Monyer et al., 1994;Geiger et al., 1995). One of the best studied with 
several techniques, including in situ hybridisation, immunohistochemistry (Catania et 
al., 1995;Catania et al., 1998), single cell-PCR combined with electrophysiology 
(Geiger et al., 1995) are α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid 
receptors (AMPAR) that underlie the mediation of fast excitatory neurotransmission 
in the brain (Keinanen et al., 1990;Sato et al., 1993). AMPARs are multimeric 
assemblies of different subunits (GluR-1-4; GluR-A-D) that form tetramers, and 
depending on the subunit composition the channel properties and hence excitatory 
transmission varies. Most interneurons, in contrast to principal cells, possess 
AMPARs that do not contain the GluR-B (GluR-2) subunit or only in small amounts. 
The unique AMPAR expression profile in interneurons translates into channels with 
high calcium permeability and fast kinetic properties (Jonas et al., 1994;Seeburg, 
1993). The slow component of excitatory synaptic transmission is mediated by the 
activation of N-methyl-D-aspartate receptors (NMDAR). These are composed of 
heterodimers comprising NR1 and NR2 (NR2A-D) subunits (Monyer et al., 
1992;Moriyoshi et al., 1991;Monyer et al., 1994) which also appear to be differentially 
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expressed in interneurons and principal cells (Dr. J. von Engelhardt, personal 
communication, ongoing work in the lab). 
 9 
  1. Introduction 
1.3. Distinct functions of interneurons in the developing and 
mature brain 
 
1.3.1. Origin of interneurons and their role during development 
 
There is an increasing body of evidence indicating that a specific GABAergic 
interneuron subtype is determined by the site and time of birth. It is of note that the 
generation and migration of GABAergic interneurons is distinct from that of principal 
cells (Parnavelas, 2000). Thus, neural precursor cells of glutamatergic principal cells 
arise from the ventricular zone of the dorsal telencephalon and migrate radially to 
their destination (Mione et al., 1997;Rakic P, 1990;Tan et al., 1998). In contrast, 
GABAergic interneurons originate from distinct regions of the subpallium of the 
telencephalon (Fig. 4) depending on the interneuronal subtype (Anderson et al., 
1997;De Carlos et al., 1996;O'Rourke et al., 1995). 
 
 
 
Fig. 4 Routes of tangential migration of interneurons from the subpallidum to the neocortex 
and the hippocampus. Coronal (a, b) and sagital sections (c) of the embryonic telencephalon 
are illustrated as well as the known (solid arrow) and hypothesised (dashed arrow) routes of 
migration. Hippocampal interneurons arise from the medial (MGE) and the lateral ganglionic 
eminence (LGE). Figure (modified) from (Corbin et al., 2001). 
Thus, in utero fate mapping studies revealed that PV- and SOM-positive interneurons 
are generated in the medial ganglionic eminence (Wichterle et al., 2001;Nery et al., 
2002) whereas CR-positive cells originate from the caudal ganglionic eminence 
(Sussel et al., 1999). They migrate tangentially from their place of birth to their final 
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position (O'Rourke et al., 1992). Birthdating studies showed that the hippocampal 
primordium starts to be colonised by GABAergic interneurons at embryonic day 15 
(Manent et al., 2006). In addition, these studies revealed that the migration of 
principal cells is dependent on GABA signalling and vice versa.  
GABAergic interneurons play a major role in brain development since they are the 
initial source of excitation in the immature brain. During embryonic and early 
postnatal development the neurotransmitter GABA is excitatory. This paradox can be 
explained by the initial absence of the K+-Cl- coupled co-transporter KCC2 (Rivera et 
al., 1999;Ganguly et al., 2001) and hence the high intracellular chloride concentration 
in immature interneurons (Ben Ari et al., 1989). Although, the excitatory action of 
GABA is thought to influence cell proliferation by acting on DNA synthesis (LoTurco 
et al., 1995) and to regulate maturation of GABAergic innervation pattern through 
neurotrophic mechanism during development (Spoerri PE, 1988) and adult 
neurogenesis (Ge et al., 2006).  
 
1.3.2. Interneurons and their role in hippocampal network activity 
 
In the mature brain interneurons shape the activity of principal cells via feedback or 
feedforward inhibition by hyperpolarising the membrane potential in the perisomatic 
or dendritic region of principal cells. Thereby they decrease the firing probability of 
targeted principal cells. During feedforward inhibition interneurons receive activation 
through extra- and intrahippocampal inputs and reduce in parallel the firing rate of 
principal cells (Fig. 5A) (Buzsaki, 1984;Lacaille et al., 1987). Whereas feedback 
inhibition is mediated by principal cells of the same hippocampal region through 
recurrent axon collaterals that excite a group of interneurons which then again 
inhibits the principal cells (Fig. 5B). Examples for these feedback mediating cells are 
basket and O-LM cells (Blasco-Ibáñez JM and Freund TF, 1995;Lacaille et al., 1987).  
By exerting their inhibition, interneurons are responsible for the generation and 
maintenance of network oscillations in populations of synaptically connected principal 
cells. Oscillations do not encode information but give a spatial and temporal structure 
to synchronous activity of different groups of principal cells. Oscillations can be 
measured in the hippocampus in different frequency bands and can be associated 
with distinct behavioural states in an animal: theta activity (4 - 12 Hz) is detectable 
during explorative behaviour (Vanderwolf CH., 1969), gamma oscillations (30 -80 Hz) 
are associated with higher cognitive functions (Gray and Singer, 1989;Buzsaki and 
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Eidelberg, 1983;Bragin et al., 1995) and sharp wave ripples and high-frequency 
oscillations (140 - 200 Hz) are observed during slow-wave sleep, awake immobility 
and consumatory behaviour (Buzsaki and Eidelberg, 1983;Buzsaki, 1986). 
 
 
 
 
Fig. 5 Principles of feedforward and feedback inhibition. A: Feedforward inhibition. A 
principal cell excites an interneuron which then reduces the firing rate of another principal 
cell. B: Feedback inhibition. A principal cell mediates excitation onto an interneuron which in 
turn inhibits again the principal cell. 
Numerous studies have indicated that fast-spiking PV-positive interneurons that 
perisomatically innervate principal cells play an important role in the generation and 
maintenance of gamma oscillations. In contrast, it is thought that interneurons 
involved in the generation of theta rhythms preferably innervate the distal dendrites of 
principal cells and are slow-spiking. These interneurons become rhythmically excited 
either by cholinergic and/or GABAergic input from the septum or by intrinsic 
oscillatory properties of hippocampal interneurons and principal cells (Buzsaki and 
Eidelberg, 1983). Furthermore, distinct interneuronal subtypes fire phase-locked to 
theta (and sharp wave ripple) oscillations (Fig. 6). In combination with the innervation 
of different domains of principal cells interneurons are thereby able to coordinate the 
activity of principal cells in a temporally distinct and brain-state-dependent manner 
(Klausberger et al., 2003). 
The role of specific GABAergic interneurons in oscillations in defined frequency 
ranges has been shown in a number of electrophysiological studies in vitro and in 
vivo, however, a causal involvement can only be hypothesised (Klausberger et al., 
2004;Gloveli et al., 2005;Whittington et al., 1995;Whittington and Traub, 2003). Their 
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direct involvement could be tested in genetically manipulated animals in which key 
molecules were turned off in selective cell populations. The ablation of the major 
neuronal gap junction protein Cx36 and hence, the gap junction-mediated electrical 
signalling in Cx36 knock-out mice, resulted in the reduced power of gamma 
oscillations whilst rhythms in other frequency ranges were not altered (Buhl et al., 
2003;Hormuzdi et al., 2001). Other genetic models that gave insight into the function 
of particular interneuronal subtypes were based on genetic modifications that lead to 
reduced excitability and hence insufficient recruitment of GABAergic interneurons 
that in turn resulted in reduced gamma oscillations (Fuchs et al., 2001;Fuchs et al., 
2007). 
 
 
 
Fig. 6 Phase-locked firing of distinct interneurons during theta oscillations. The firing of 
interneurons depends on the subtype. Basket cells fire preferably at the descending phase of 
the theta wave in contrast to axo-axonic cells that fire around the peak or O-LM cells that 
discharge at the trough. Figure (modified) from (Somogyi and Klausberger, 2005). 
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1.4. Influencing the interneuronal communication by genetic 
manipulations 
 
The elucidation of the role of distinct GABAergic interneurons at a cellular and 
network level during development and in the adult requires genetic alterations that 
are specific for the given cell population. It is possible to specifically change the 
excitability of defined GABAergic interneurons or to ablate key molecules that might 
affect crucial functions. The effect can be subsequently studied in vitro (e.g. cell 
culture, acute slice preparation) and/or in vivo (electrophysiology, behaviour). 
Currently, the most frequently used approach to ablate genes in specific subsets of 
cells is the CRE/loxP system (Kwan, 2002;Nagy, 2000).  
 
1.4.1 CRE/loxP system 
 
Recombination occurs in all organisms and is promoted by recombinases, specific 
enzymes that catalyse cleavage and religation of the modified DNA. The 
physiological function of these enzymes is to repair DNA if necessary and to provide 
a way of changing the genomic arrangement thereby creating genetic diversity.  
The finding that some bacteria and yeast recombinases are able to also catalyse 
excision, integration, inversion and translocation of DNA in eukaryotic systems, 
opened up new possibilities of genetic engineering. The two recombinases that are 
commonly used for this purpose are a recombinase derived from the P1 
bacteriophage (CRE) (Abremski and Hoess, 1984;Hamilton and Abremski, 1984) and 
one from Saccharomyces cerevisiae (flp) (Broach et al., 1982;Dymecki, 1996). Both 
belong to the integrase family of site-specific recombinases.  
The molecular mechanism of the recombination event will be explained exemplifying 
the CRE recombinase. CRE recombinase is a 38 kDa protein that recognizes a 34 bp 
consensus sequence, called loxP site, consisting of two palindromic 13 bp flanking 
sequences separated by an 8 bp asymmetric core spacer sequence, that determines 
the orientation of the recognition site (Fig. 7A). For CRE recombinase-mediated 
recombination to occur two loxP sites are required. A CRE recombinase molecule 
binds to each palindromic half of two loxP site and then CRE recombinase forms a 
tetramer that brings the two loxP sites together. Thus allowing recombination within 
the two spacer areas of the loxP sites (Voziyanov Y et al., 1999). After the 
recombination event one loxP site remains consisting of the other palindromic halfs 
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of both former loxP sites, respectively. Depending on the orientation of the 
recognition sites, cis or trans, a floxed DNA fragment can either be excised or 
inversed (Fig. 7B). 
 
 
 
Fig. 7 Scheme of the Cre/loxP system. A: Structure and sequence of the loxP and FRT 
recombinase recognition site. They consist of two 13 bp inverted repeats and an 8 bp core 
sequence that defines the orientation of the site (indicated by arrowheads). B: Scheme of 
CRE recombinase mediated trans and cis recombination between two recognition sites 
(orientation is indicated by the arrowheads) and the resulting products. Adapted from (Kwan, 
2002;Nagy, 2000). 
 
Initially many studies resorted to the CRE/loxP system because it provided the higher 
recombination efficiency compared to the FLP/frt system. The reduced recombination 
efficacy of the FLP recombinase is due to the decrease of its enzymatic stability at 
37°C (Buchholz et al., 1996). However, some modifications have recently improved 
the thermo-stability of FLP (FLPe) and offered an alternative to the CRE/loxP system 
which is equally powerful (Rodriguez et al., 2000).  
The Cre/loxP system aiming at targeted gene disruption in specific cell populations 
requires the combined use of homologous recombination in mouse embryonic stem 
cell and transgenic techniques. To this end two mouse lines need to be generated: 
one carrying the floxed gene of interest and the other expressing CRE recombinase 
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under the control of a subtype-specific promoter. The latter can be achieved either by 
transgenic techniques or by homologous recombination in embryonic stem cells. 
The most common way to use the CRE/loxP system to ablate gene functions are 
either to create a mouse line that expresses the CRE recombinase under a cell-type 
specific promoter and cross it with a transgenic mouse line that expresses the floxed 
gene of interest or vice versa (Fig. 8) (Gu et al., 1993).  
One of the first approaches using CRE recombinase-mediated activation of a 
targeted gene in mice was performed by Lakso et al. (Lakso et al., 1992).  They 
generated mice carrying a lens-specific αA-crystallin promoter separated from a 
SV40 tumor antigen gene sequence by a floxed stop-cassette. These mice were 
crossed with mice expressing CRE recombinase under distinct promoters and in the 
progeny the excision of the stop-cassette resulted in the formation of lens tumors.  
 
 
 
Fig. 8 Scheme illustrating cell-type specific gene ablation using the CRE/loxP system. The 
‘loxP mouse’ (right) possesses a floxed targeted gene (loxP sites are indicated by black 
arrowheads) and the CRE mouse drives CRE recombinase under a cell-type specific 
promoter (P). Mice from the two lines are intercrossed and in the progeny gene function is 
disrupted in cells that express Cre recombinase but not in cells lacking CRE recombinase 
expression.  
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To monitor the expression pattern of CRE recombinase and simultaneously test the 
functionality of the recombinase, CRE recombinase-expressing mice are bred with 
reporter mice. A commonly used reporter line is ROSA26 (R26R, (Soriano, 1999)) in 
which the modified locus guarantees the ubiquitous expression during development 
and in the adult mouse. Soriano and colleagues identified the ROSA26 locus by 
random retroviral gene trapping in embryonic stem cells (Zambrowicz et al., 1997). In 
R26R mice a modified lacZ cassette that is normally not transcribed is inserted in the 
ROSA26 locus. The cassette contains a splice acceptor site (SA) as in the original 
gene-trap allele and a NEO expression cassette flanked by loxP sites followed by the 
lacZ gene. Upon CRE recombinase-mediated removal of the NEO cassette the lacZ 
gene is transcribed and its product β-galactosidase can be visualised by 
immunohistochemical methods (Fig. 9).  
 
  
 
Fig. 9 ROSA26 CRE reporter mouse line (R26R). A: Targeted ROSA26 locus with an 
expression cassette consisting of a splice acceptor sequence (SA) upstream of the floxed 
NEO cassette and a lacZ gene followed by a polyadenylation sequence (bpA) downstream of 
the NEO cassette. After CRE mediated excision of the NEO cassette, the ROSA26 promoter 
drives the lacZ gene expression. Arrowheads indicate loxP sites. B: LacZ expression after 
CRE recombinase mediated recombination. X-Gal whole mount staining of E9 R26R (left) 
and R26R/R26Cre compound heterozygous embryos (right). C: X-Gal staining of a sagital 
section of an E9 R26R/R26Cre compound heterozygous embryo (left) and higher 
magnification of the somites of that embryo (right). Adapted from (Soriano, 1999). 
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The following two paragraphs will describe the characteristics and expression pattern 
of the two genes - GAD67 and somatostatin - that were chosen in this study to 
generate cell-type specific CRE recombinase expressing mice. 
 
1.4.2. GAD67- a common feature of interneurons 
 
A general feature that applies to almost all interneurons is the expression of GAD67, 
together with GAD65, one of the major GABA synthesising enzymes (Erlander et al., 
1991). GAD67 is responsible for 90% of the synthesis of GABA (Asada et al., 
1997;Condie et al., 1997).  
The murine GAD67 gene is localised on chromosome 2 (Brilliant et al., 1990) and 
comprises a gene with an approximate size of 70 kb. Out of these 70 kb, 42 kb 
encode the 18 exons and at least 20 kb account for the 5’ regulatory elements 
(Szabo G et al., 1996). The translational start codon is situated on exon 2. The 5’ 
flanking region of the GAD67 gene (Fig. 10) consists of three transcriptional initiation 
sites with its promoters P1-P3 as well as neuron-specific silencer and region-specific 
enhancer elements (Katarova et al., 1998;Erlander and Tobin, 1992;Szabo G et al., 
1996). Different combinations of the promoters and the regulatory elements lead to 
the expression of three distinct GAD67 transcripts in a developmental and tissue-
specific manner. GAD67 expression, for instance, in the cerebellum, which develops 
postnatally, requires the most upstream promoter P3 (Katarova et al., 1998). 
 
 
 
Fig. 10 Schematic representation of the promoter region of the GAD67 gene. The grey boxes 
indicate the start sites of transcription under the control of the corresponding promoters: the 
proximal housekeeping promoter (P1) composed of the GC box, two distal conventional 
(TATA) promoters (P2, P3). In addition, a neuron-restrictive silencer element (NRSE) and a 
negative regulatory element (NRE) are shown. 
 
Furthermore, studies from Szabo et al. showed that the GAD67 gene is subjected to 
post-transcriptional modification during development which is the alternative 
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bicistronic splicing of exon 7 to obtain GAD25 (leader peptide) and the embryonic 
active form GAD44 (Szabo et al., 1994). 
Concerning the mRNA expression, the two embryonic forms of GAD67 (GAD25, 
GAD44) and GAD67 can be detected as early as embryonic day 10.5 in the mouse 
brain (Katarova Z et al., 2000). Immunohistochemical staining for GAD67 
demonstrates that it is present both in the cell body and  proximal dendrites as well 
as in axon terminals (Fig. 11) (Esclapez et al., 1994;Kaufmann DL et al., 1991). 
 
 
 
Fig. 11 GAD67 protein expression in the adult mouse brain. Immunohistochemical staining of 
coronal sections of an adult mouse with an anti-GAD67 antibody (red signal). A: GAD67 
expression pattern in the hippocampus. B: Distribution of GAD67 expression in the cerebral 
cortex. Inset illustrates a higher magnification of cortical cells. Hi: Hippocampus; DG: Dentate 
gyrus. Scale bars: 250 µm. 
 
Until now, several transgenic mice using the GAD67 gene have been generated. 
Reporter lines expressing EGFP under the GAD67 promoter helped to further 
characterise GABAergic projection neurons in the neocortex (Tomioka et al., 2005). 
Furthermore, they helped to identify factors modulating the migration of hippocampal 
interneurons during development (Manent et al., 2006). Knock-out approaches 
showed that the absence of GAD67 leads to neonatal lethality due to cleft palate and 
a reduced GABA content but major structural defects in the brain were not detectable 
(Asada et al., 1997;Condie et al., 1997). Mice heterozygous for the modified GAD67 
allele were viable. Hence the GAD67 promoter is a powerful tool to drive CRE 
recombinase expression selectively in this cell population. These mice can be used 
for subsequent gene deletion that will affect all GABAergic interneurons of the 
nervous system. 
  1. Introduction 
1.4.3. Somatostatin 
 
Somatostatin was initially described as a regulatory hormone of the hypothalamus 
(Brazeau et al., 1973) but later additional physiological functions were revealed. It is 
expressed in a subset of GABAergic interneurons (Freund and Buzsaki G, 1996) and 
serves as a neurotransmitter as well as neuromodulator (Patel, 1999). In the 
hippocampus it has been shown that somatostatin presynaptically inhibits excitatory 
transmission by reducing glutamate release. The postsynaptic inhibitory effects are 
dependent on the reduction of voltage-activated Ca2+ currents (Vilchis et al., 
2002;Wang et al., 2002;Wang et al., 1990) and the potentiation of voltage-dependent 
outward K+ currents (Moore et al., 1988;Watson and Pittman, 1988). Both, the pre- 
and the postsynaptic effects are mediated by somatostatin receptors that comprise 
five subtypes and belong to the G-protein-coupled receptor family (Hoyer et al., 
1995). However, also excitation of principal cells of the subiculum and the CA1 
region mediated by somatostatin were demonstrated (Dood and Kelly, 1978;Vilchis et 
al., 2002;Wang et al., 2002;Greene and Mason, 1996). 
 
 
 
 
Fig. 12 The 5’ flanking region of the somatostatin gene and its regulatory elements. The 
main regulatory elements are the cAMP responsive element (CRE), an upstream enhancer 
element (UE), two proximal silencers 1 and 2 and the tissue-specific enhancer (T1 – T3). The 
numbers indicate the nucleotides relative to the transcriptional start codon (ATG). Figure 
adapted from (Burbach, 2002;Schwartz and Vallejo, 1998)a). 
The somatostatin gene, located on chromosome 16 of the mouse (Lalley PA et al., 
1987;Montminy et al., 1984), consists of two exons with the translational start codon 
located on exon 1 (Fuhrmann et al., 1990). Including the 5’ and 3’ untranslated 
regions the somatostatin gene covers 2.5 kb. The promoter region (Fig. 12) 
possesses a cAMP-response element (Montminy et al., 1986;Montminy and 
Bilezikjian, 1987) and an upstream enhancer  element  that binds homeodomain 
proteins (Vallejo et al., 1992a). The latter is responsible for high expression levels in 
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the pancreas and seems to function as a repressor in neural cells (Schwartz and 
Vallejo, 1998). 
The somatostatin biosynthesis consists of the production of precursor molecules 
(prosomatostatin) followed by post-translational cleavage into several peptides 
(Funckes et al., 1983;Goodman et al., 1983). The two main bioactive forms are 
somatostatin-14 (Brazeau et al., 1973) and somatostatin-28 (Pradayrol et al., 1980) 
which are expressed in the brain and the guts, respectively .  
Somatostatin mRNA can be already detected at mouse embryonic day (E) E7.5 in 
the foregut (Gittes and Rutter, 1992). In the brain, somatostatin mRNA is detectable 
in several regions at E14, the mRNA levels increase in the first three postnatal weeks 
and then decrease to the adult expression level (Bendotti C. et al., 1990). The 
expression is also ontogenetically regulated, since expression in the cerebellum is 
upregulated during early postnatal development and is negligible in the adult. 
 
 
 
Fig. 13 Expression of somatostatin in the adult mouse brain. Somatostatin-immunostaining 
of coronal sections of an adult mouse brain (brown signal). A: Expression pattern of 
somatostatin in the hippocampus. B: Somatostatin-positive cells in the cerebral cortex. Hi: 
Hippocampus; DG: Dentate gyrus. Scale bars: 250 µm. 
 
Approaches to genetically modify the expression of somatostatin include the 
complete knock-out of somatostatin itself (sst-KO) (Buckmaster PS et al., 
2002;Cammalleri et al., 2006) and the somatostatin receptor 2 (sst2-KO) (Dutar et 
al., 2002). No obvious physiological or anatomical defects of the brain or other 
organs could be detected. The sst-KO showed elevated plasma growth hormone 
levels and significant impairment concerning motor learning (Zeyda et al., 2001). The 
sst2-KO mice exhibited a slightly increased short-term potentiation and improved 
spatial discrimination learning (Dutar et al., 2002). The absence of more noticeable 
 21 
  1. Introduction 
deficits in sst-KO mice is surprising considering the many important physiological 
functions of somatostatin and might be explained at least in part by compensatory 
mechanisms. However, the lack of major alterations in sst-KO mice can be 
considered an advantage if one plans to use the somatostatin promoter to drive CRE 
recombinase expression. Moreover, in the planned genetic alteration only one 
somatostatin allele will be modified by the knock-in of CRE recombinase that will not 
influence the viability of the transgenic mice.  
 
1.5. Aim of the study 
 
Despite the fact that GABAergic interneurons only comprise about one fifth of all 
neurons in the brain they have a great influence on developmental processes as well 
as network activity in the mature brain. During development of the brain they are able 
to modulate cell proliferation, migration of neurons as well as differentiation and 
synaptogenesis. In the adult brain interneurons inhibit principal cell activity and thus 
are responsible for shaping and maintenance of network oscillations. 
To gain more insight into the function of interneurons and their molecular 
components in the above-mentioned processes, celltype-specific ablation of genes of 
interest is a powerful tool. An approach to perform such experiments is to apply the 
CRE/loxP system that is based on CRE recombinase-mediated site-specific 
recombination of loxP-sites that flank the gene of interest. Two promoters were 
chosen to drive CRE recombinase expression, the GAD67 promoter that ensures 
expression in all GABAergic interneurons and the somatostatin promoter, that limits 
the manipulation to a specific interneuronal subpopulation. 
The aim of this study was to generate and analyse two mouse lines expressing CRE 
recombinase under the control of the GAD67 and somatostatin promoter, 
respectively. These transgenic mice were generated via a knock-in approach that 
was performed by homologous recombination in embryonic stem cells. After breeding 
CRE-expressing mice with ROSA26 reporter mice, the pattern of CRE recombinase 
expression and the functionality of the recombinase was verified using 
immunohistochemical methods. Ablation of the trkB receptor in all GAD67-positive 
cells as well as of the NR1 subunit of NMDAR and the GluR-A subunit of AMPAR in 
somatostatin-expressing cells are currently in progress. 
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2. Materials and Methods 
 
2.1. Materials 
 
2.1.1. List of oligonucleotides 
 
All oligonucleotides were synthesised by Invitrogen GmbH (Karlsruhe, Germany).  
 
2.2.1.1. Oligonucleotides for cloning the SOM/CRE-targeting construct  
 
5’ Rt for  ATAAGAATGCGGCCGCCTGCTGTTCCCGAGTAGGTG 
5’ Rt rev  GGGTTCGAACCTCCTATCTCTCCTACTGG 
3’ Rt for  CCCAAGCTTTCTCGTTTATGTTCCAATGT 
3’ Rt rev  CCTGATCAATAAGTGAGGCGAGCGAGAT 
5’ Tg for  GGGGTACCGTGCAGGCTTTCTTTTTC 
5’ Tg rev  GGACATGTTCCTTGCCTCAGG   
3’ Tg for  GAAGATCTCTGTCCTGCCGTCTCCA 
3’ Tg rev  TATCAAATCGCCGGCGAGGGGACCCTAACTTCAA 
 
2.1.1.2. Oligonucleotides for sequencing 
 
T3   AATTAACCCTCACTAAAGGG 
T7   TAATACGACTCACTATAGGG 
SOMs7586  AAGTCTCACTCGCCATACAA 
NEO 1as  CCCGCTTCAGTGACAACGTCGAGCACA 
NEO 3as   CTTGAGCCTGGCGAACAGTTCGGC 
NEO Rayb   GCGATGCCTGCTTGCCGAATA 
Cre1s   CGCCTGCTGGAAGATGGCGATTAG 
rspcre-2  AGGCTAAGTGCCTTCTCTACAC 
Cre2as  CATTGGTCCAGCCACCAGCTTGCA 
Cre3s   GCCATCTGCCACCAGCCAGCTATC 
Cre3as  TCAGTGCGTTCGAACGCTAGAGCC 
Cre5up  GGCAAATTTTGGTGTACGGTC 
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2.1.1.3. Oligonucleotides for genotyping  
 
Ye-GAD5’  CCGGCGCCCCTTAGCTGTGAG 
5Creup2  GGTTCTTGCGAACCTCATCACTCG 
rspneo4  GGCTATTCGGCTATGACTGGGC 
rspneo5  GGGTAGCCAACGCTATGTCCTG 
flp1   CACTGATATTGTAAGTAGTTT 
flp2   CTAGTGCGAAGTAGTGATCAGG 
rspcre1  ACCAGGTTCGTTCACTCATGG 
rspcre2  AGGCTAAGTGCCTTCTCTACAC 
LacZ7   CCCATTACGGTCAATCCGCCG 
LacZ8   GCCTCCAGTCAGCGCGGCTG 
NR1-1  AGGGGAGGCAACACTGTGGAC 
NR1-2  CTGGGACTCAGCTGTGCTGG 
MM60   CACTCACAGCAATGAAGCAGGAC 
3int3   CTGCCTGGGTAAAGTGACTTGG 
 
2.1.1.4. Oligonucleotides for generating probes for Southern blot analysis 
 
5’probe II for  CTTAGTAGCCCAACACCCAC 
5’probe II rev   TTTGTTCTTGCTGTGTCCTC 
3’probe for  GAGCGTCTGAAAACTTAGCA 
3’probe rev  CCTGTTCCTCCAGCAATAAT 
 
2.1.1.5. Oligonucleotides for in situ hybridisation 
 
SOM oligo1 AGCCAAGCTGGAGCGCGGTGGGTCAGTCTAGTCGCAGGTCCTCAG 
SOM oligo2 TGGGGCAAATCCTCGGGCTCCAGGGCATCATTCTCTGTCTGGTGG 
SOM oligo3 AAGTTGAGCATCGGGGGCCAGGAGTTAAGGAAGAGATATGGGGTT 
 
2.1.2. Bacterial strains 
 
DH5α: Stratagene 
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2.1.3. Cell lines 
 
Feeder cells: Primary mouse fibroblasts from E13.5 NMRI embryos. 
R1 ES cells:  Pluripotent mouse embryonic stem cells (passage number 11) derived 
from the inner cell mass of 129/SV x 129/SVJ- mouse blastocysts (Nagy 
et al., 1993). 
E14 ES cells: Provided by Prof. P. Offermanns, Institute of Pharmacology, University 
   of Heidelberg, Germany. 
 
2.1.4. Mouse strains 
 
C57Bl/6   (from Charles River, Germany) 
ROSA26  (Soriano, 1999) 
Flp deleter  (Rodriguez et al., 2000) 
NR12lox  (Shimshek et al., 2006) 
GluRAneo  (Zamanillo et al., 1999) 
 
2.1.5. Antibodies 
 
Primary antibodies and used dilutions:  
 
mouse anti-β-actin (Sigma)   1:20000 
mouse anti-Calbindin (Swant)   1:5000 
mouse anti-GAD67 (Chemicon)   1:3000 
rabbit anti-GAD67 (Chemicon)   1:1000 
rabbit anti-β-galactosidase (Cappel)  1:3000 
mouse anti-Parvalbumin (Sigma)  1:3000  
rat anti-somatostatin (Chemicon)  1:1000 
 
Secondary antibodies and used dilutions: 
 
CyTM3-conjugated AffiniPure goat anti-mouse/rabbit/rat antibodies (Dianova) 1:1000 
AlexaFluor488/555 (Invitrogen)       1:1000 
Biotinylated anti-mouse/rabbit/rat IgG (H+L) (Vector Laboratories)   1:400 
Peroxidase anti-mouse/rabbit IgG (H+L) (Vector Laboratories)   1:20000 
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2.1. Methods 
 
2.2.1. Molecularbiological methods 
 
Standard molecularbiological methods were performed as described in Sambrock et 
al. (Sambrock J. et al., 1989). The isolation and purification of DNA were performed 
with the Plasmid Mini/Midi-Kit, the PCR Purification Kit and the Gel Extraction Kit 
from Qiagen (Hilden, Germany) according to the manual provided by the 
manufacturer. 
 
2.2.2. Sequencing 
 
The sequencing of the cloned constructs was performed by Horst Grosskurth at the 
MPI for Medical Research (Heidelberg, Germany). It was carried out following the 
‘Dye Terminator Cycle Sequencing’ protocol (96oC, 15 s; 55oC, 15 s; 60oC, 4 min; 25 
cycles) from ABI. 
 
2.2.3. In situ hybridisation with radioactive-labelled probes 
 
Mice were anaesthetised with isoflurane, brains were removed from the skull, frozen 
immediately, cut on a microtom-cryostat (14 µm) and thaw-mounted to poly-L-lysine-
coated slides. Then sections were fixed with 4% paraformaldehyde in phosphate 
buffer pH 7.4, dehydrated in ethanol and stored in 100% ethanol at 4°C.  
In situ hybridisation experiments with 35S-labeled oligonucleotide probes were 
performed as previously described in Wisden et al. (Wisden W and Morris BJ, 2002). 
Briefly, the oligonucleotides were 3’ end labelled using terminal deoxynucleotidyl 
transferase and [α-35S]dATP. Sections were hybridised overnight at 42°C in 50% 
formamide, 0.6 M NaCl, 0.06 M sodium citrate (4x SSC), 10% dextrane sulfate with 1 
pg/µl probe. Non-specific labelling of the sections was assessed by hybridising 
labelled oligonucleotide in the presence of 100-fold excess of unlabelled 
oligonucleotide. Subsequently, the sections were washed in 1x SSC at 55°C for half 
an hour and dehydrated in ethanol. Exposure time to Kodak XAR-5 film was 14 days. 
Three oligonucleotides specific for the somatostatin gene were chosen and gave 
identical results. The nomenclature used for the analysis of the in situ hybridisation 
study follows that of Altman and Bayer, Franklin and Paxinos (Altman J. and Bayer 
S.A., 1995;Franklin K.B.J. and Paxinos G., 1997;Paxinos G. et al., 1994). 
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2.2.4. X-Gal staining 
 
5-Bromo-4-chloro-3-indolyl-β-D-galactosidase (X-Gal) staining was performed as 
previously described (Bonnerot and Nicolas JF, 1993). Briefly, mice were 
anaesthetised by intra-peritoneal injection of ketamine hydrochloride and xylazine 
hydrochloride, and perfused through the ascending aorta with 4% paraformaldehyde 
in phosphate buffer pH 7.4 (PBS). Brains were removed from the skull, postfixed for 
two hours at 4°C in 4% PFA and stored in 1× PBS at 4°C until use. Brains were 
blocked in 4% agar (1x PBS), cut at a vibratome (50 µm; Leica VT1000S) and the 
sections were stored in 1x PBS at 4oC. Embryos were fixed in 4% paraformaldehyde 
in phosphate buffer pH 7.4 (PBS) for 1 hour at 4oC, washed in 1x PBS and 
equilibrated in 30 % sucrose in 1x PBS overnight at 4oC. Embryos were punctured at 
the neck to allow better penetration of the paraformaldehyde and sucrose solutions. 
Subsequently, 18 µm cryostat sections were prepared. 
For the X-Gal staining both the free floating sections as well as the cryostat sections 
were washed three times with 1x PBS and transferred to the staining solution (5 mM 
K4Fe(CN)6, 5 mM K3Fe(CN)6, 2 mM MgCl2, 2 mg/ml X-Gal in 
dimethylformamide/1xPBS). The sections were incubated at 37oC in the dark for 10 
to 15 minutes. Subsequently, they were washed three times for 5 minutes with 1x 
PBS. Sections were either mounted on slides and counter-stained with Neutral Red 
solution (Sigma) or further processed for immunohistochemical staining experiments. 
For imaging, an Olympus BX51 microscope that was connected to a camera system 
from INTAS was used. The applied software was MagnaFire 2.1C. The nomenclature 
used for the analysis follows that of Altman and Bayer, Franklin and Paxinos (Altman 
J. and Bayer S.A., 1995;Franklin K.B.J. and Paxinos G., 1997;Paxinos G. et al., 
1994). 
 
2.2.5. Immunohistochemistry 
 
Mice were anaesthetised by intra-peritoneal injection of ketamine hydrochloride and 
xylazine hydrochloride, and perfused through the ascending aorta with 4% 
paraformaldehyde in phosphate buffer pH 7.4. Brains were removed from the skull, 
postfixed for two hours at 4°C in 4% PFA and stored in 1× PBS at 4°C until use.  
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Brains were blocked in 4% agar (dissolved in 1x PBS), cut on the vibratome (50µm; 
Leica VT1000S) and the sections were either stored in 1x PBS at 4°C or washed four 
times for 10 minutes in order to proceed with the immunohistochemical staining. 
Sections were incubated first in 10% sucrose/1xPBS for 15 minutes at room 
temperature and in 30% sucrose/1xPBS over night at 4°C. Permeabilisation of the 
sections was performed by repeated (4-5 times) freezing (over liquid nitrogen) and 
defrosting (55°C). To remove the sucrose four washing steps with 1x PBS (each 10 
minutes) followed. Sections were incubated in 1% H2O2 in 1x PBS for 10 minutes and 
washed with 1x PBS four times for 10 minutes. For blocking unspecific binding sites, 
sections were incubated 45 minutes in 5% BSA/1x PBS at room temperature. 
Primary antibodies were diluted in 1x PBS and incubated for 24 hours at 4°C. The 
antibody dilutions were: rat anti-somatostatin (Chemicon) 1:1000, mouse anti-GAD67 
(Chemicon) 1:3000, rabbit anti-GAD67 (Chemicon) 1:1000, rabbit anti-β-
galactosidase (Cappel) 1:3000, mouse anti-Parvalbumin (Sigma) 1:3000, mouse 
anti-Calbindin (Swant) 1:5000. For double labelling experiments incubation with both 
primary antibodies were carried out at the same time. After washing three times with 
1x PBS sections were incubated for two hours at room temperature with the 
secondary antibody for the DAB staining: biotinylated anti-rat, anti-rabbit or anti-
mouse IgG (Vector Laboratories) 1:400 in 1x PBS. To enhance the staining reaction 
sections were incubated with an avidin-biotin complex (ABC Elite Kit, Vector 
Laboratories) for 90 minutes. Two washing steps with 1x PBS and two with 20 mM 
TRIS-HCl buffer pH 7.6 (TRIS), each for 10 minutes, followed. Sections were 
incubated in DAB solution (0.4 mg/ml, Sigma) for 20 minutes. The staining reaction 
was started by adding 0.01% H2O2 and stopped by transferring the sections to TRIS-
buffer. Three washing steps with TRIS buffer followed. For developing a second 
primary antibody slices were washed additionally with 1x PBS and incubated with the 
fluorescent secondary antibody (CyTM3-conjugated AffiniPure goat anti-
rabbit/mouse/rat antibodies (Dianova) 1:1000; AlexaFluor488/555 (Invitrogen) 
1:1000) at RT for two hours. Three final washing steps in TRIS buffer were 
performed before the sections were mounted with gelatine on microscopic glass 
slides. After the sections were dried, they were cover-slipped with Mowiol. For 
imaging an Olympus BX51 microscope  that was connected to a camera system from 
INTAS was used. The applied software was MagnaFire 2.1C. 
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2.2.6. Mouse embryonic stem cell culture 
 
Pluripotent embryonic stem cells (cell line R1) were cultured either on primary mouse 
fibroblasts (mitomycin C-treated, Sigma) or on gelatine-coated (0.1 %) culture dishes 
in ES cell medium (containing Dulbecco’s modified Eagle medium supplemented with 
2 mM L-glutamine (Gibco), 0.1 mM non-essential amino acids (Gibco), 1 mM 
sodiume pyruvate (Gibco), 10-4 M β-mercaptoethanol (Sigma), 20% fetal calf serum 
(PAN Biotech GmbH), 50 µg/ml penicillin and streptomycin (Gibco) and 1000 U/ml 
leukaemia inhibitory factor (Gibco).  
For transfection of the ES cells, plasmid DNA containing the targeting construct was 
linearised with NotI and purified with gelfiltration-columns (Chroma Spin TE-1000). 
The electroporation (BioRad Genpulser, 500 µFD, 240 V) of ES-cells suspension was 
performed with 30 µg of linearised DNA. Transfected ES-cells were selected with 
G418 for 4 days with different concentrations: 1. and 2. day: 175 µg/ml; 3. day: 280 
µg/ml; 4. day: 350 µg/ml. Resistant clones were isolated and further expanded to 
extract genomic DNA to screen for positive clones by applying Southern blot 
analysis. Positive clones were expanded and frozen until the blastocyst-injection.  
 
2.2.7. Generation and care of transgenic mice 
 
Mouse blastocyst injection was performed by Frank Zimmermann (IBF, University of 
Heidelberg, Germany). For details of this procedure see Hogan et al. (Hogan B. et 
al., 1994). Animals are kept according to the animal welfare law 
(Regierungspräsidium Karlsruhe, Germany) in the animal facility of the University of 
Heidelberg (IBF). 
 
2.2.8. Genotyping of transgenic mice by PCR analysis 
 
Mouse tail biopsis were digested by incubating them for two hours at 55°C in TENS 
buffer (50 mM TRIS-HCl pH 8.0, 100 mM EDTA, 100 mM NaCl, 1% SDS) that 
contained proteinase K (1 mg/ml). After precipitation with one volume of isopropanol 
and washing with 70% ethanol, the genomic DNA was resuspended in 250 µl 1x TE 
buffer (1 mM TRIS, 0.1 mM EDTA pH7.6) for one hour at 55°C. For PCR analysis 2 
µl of the dissolved genomic DNA was used in a total volume of 25 µl reaction mix that 
contained PCR buffer (Invitrogen), 2 mM MgCl2, dNTPs (0.2 mM per nucleotide), 
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specific oligonucleotides (0.4 µM each), 0.5U Taq polymerase (Invitrogen) and sterile 
water. The conditions for the PCR dependent on the genotypes of the mice that had 
to be analysed and are listed below: 
 
1. Initial denaturing step:  95°C, 3 minutes 
2. Denaturing:   94°C, 30 seconds 
 
Oligonucleotides 3. Annealing 
temperature, time 
4. Elongation 
temperature, time 
Size of PCR product 
 
5’Tg for/5 Creup2 55°C, 30 seconds 72°C, 40 seconds 391 bp 
YeGAD5’/5Creup2 53°C, 30 seconds 72°C, 40 seconds 400 bp 
rspNEO4/rspNEO5 53°C, 30 seconds 72°C, 40 seconds 625 bp 
rspcre1/rspcre2 53°C, 30 seconds 72°C, 40 seconds 227 bp 
flp1/flp2 53°C, 30 seconds 72°C, 40 seconds 700 bp 
LacZ7/LacZ8 53°C, 30 seconds 72°C, 40 seconds 410 bp 
NR1-1/NR1-2 55°C, 30 seconds 72°C, 45 seconds wt allele: 455 bp 
mutant allele : 532 bp 
MM60/3int3 53°C, 20 seconds 
 
72°C, 20 seconds 
 
wt allele: 190 bp 
mutant allele: 250 bp 
 
Steps 2 to 4 were repeated 34 times, followed by a final elongation step at 72°C for 5 
minutes. The PCR product was determined by gel electrophoresis.  
 
2.2.9. Behaviour 
 
The behavioural studies were performed by Dr. Elke Fuchs (Department of Clinical 
Neurobiology, University of Heidelberg, Germany). GAD67CRE mice and their wildtype 
littermates (age: 3-4 month, weight: 22-28 g) were maintained at the standard animal 
facilities in polypropylene macrocolon cages with food and water ad libitum. Light 
was on from 7 a.m. to 7 p.m. and the temperature and humidity were kept at 20 ± 1 
°C and 50 ± 10%, respectively. Animal tests were approved by the 
Regierungspräsidium Karlsruhe (Germany). The testing person was not aware of the 
genotype of the animals. For the behavioural tests six GAD67CRE/+ and seven control 
mice were used. 
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Rotarod test:  
Mice were put on an accelerating rotarod (TSE Systems, Bad Homburg, Germany, 
model V4.0) that was used with a starting speed of 4 rpm.  The rotation speed 
increased from 4 to 40 rpm over a six minutes period. The test was performed on 
three consecutive days with three trials per mouse each day.  
 
Open field test: 
The open field is a grey PVC enclosed area (50 x 30 x 18 cm) that is divided into 10 x 
10 cm squares. The mouse was placed into one corner facing the walls and its 
behaviour was observed for five minutes. The number of crossed squares and the 
number of rearings were recorded and analysed on two consecutive days. 
 
Novel object recognition:  
Mice were placed for five minutes into an open field arena with two different objects 
and the time spend with each object was measured. Following a five minutes break 
one object was exchanged and again the time spent with the objects was measured 
for five minutes. This test was repeated on three consecutive days. 
 
2.2.10. Electrophysiology 
 
The electrophysiological recordings were performed by Dr. Jakob von Engelhardt 
(Department of Clinical Neurobiology, University of Heidelberg, Germany). 
Hippocampal slices (250 µm) were prepared from brains of P14 or P28 old mice. 
Cells were visualized by infrared differential-contrast video microscopy and identified 
by their firing pattern upon current injection. Whole-cell voltage clamp recordings 
were performed in cells that were located in the stratum oriens (O-LM cells). 
AMPA/NMDA ration measurements were performed as previously described (Fuchs 
et al., 2007). To test whether the somatostatin-positive cells of SOMCRE/+;GA-/- mice 
still possess fast excitatory currents, voltage clamp recordings at –70 mV with 
extracellular stimulation were performed. GABA currents were blocked by bath 
application of 10 µM gabazine and the blockade of NMDA currents was performed by 
adding 1 mM magnesium to the extracellular solution and by holding the cells at a 
potential of – 70 mV. 
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3. Results 
 
In this study the CRE/loxP system (Kwan, 2002;Nagy, 2000) was applied to generate 
genetically modified mice with CRE recombinase expression in selected cell 
populations with the aim to subsequently ablate selected genes in these cells. Two 
mouse lines expressing CRE recombinase under a subtype-specific promoter where 
generated, one that expresses CRE recombinase under the control of the glutamic 
acid decarboxylase (67 kDa isoform) (GAD67) promoter and one that expresses 
CRE recombinase under the control of the somatostatin promoter. These mouse 
lines were established via a knock-in approach and were named GAD67CRE/+ and 
SOMCRE/+. Subsequent to germline transmission of the targeting constructs, the 
transgenic mice were bred with flp-deleter mice (Rodriguez et al., 2000) to remove 
the NEO cassette and were backcrossed with C57Bl/6 mice to obtain a uniform 
genetic background. CRE recombinase functionality was tested by breeding 
transgenic mice with ROSA26 reporter mice (Soriano, 1999) followed by analysing 
sections obtained from progeny brains with immunohistochemical methods. 
 
3.1. Generation and analysis of the GAD67CRE/+ mouse line 
 
3.1.2. Cloning of the targeting construct and production of targeted ES cell 
clones 
 
The GAD67 gene spans 16 exons and the translational startcodon is located on exon 
2. To generate mice expressing CRE recombinase under the GAD67 promoter, the 
CRE recombinase cDNA was placed 30 bp upstream of the translational startcodon. 
Cloning of the targeting construct, homologous recombination in embryonic stem 
(ES) cells and screening for positive clones was performed by Dr. Irinel Coserea 
(Abbott, Ludwigshafen, Germany).  
For the targeting construct pBluescript SK+ (pBS) was used as a backbone and 
consisted of a CRE recombinase cassette (pMC-CRE recombinase, (Gu et al., 
1993)) followed by a NEO cassette containing the neomycin resistance gene 
(neomycin phosphotransferase, NEO) for selection in ES cell culture. Dr. Irinel 
Coserea modified the original vector with the NEO cassette (Cope et al., 2004) by 
removing the loxP site located at the 3’ end such that the NEO cassette was flanked 
by two frt sites. At the 5’ and 3’ end of the targeting construct two recombination arms 
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(RA) with a length of 270 and 250 bp, respectively, were located. These were used to 
introduce the targeting construct via homologous recombination in yeast (Storck et 
al., 1996) into the correct position in the YCplac22 shuttle vector. The vector 
contained a 21 kb NotI-SalI fragment of the murine GAD67 gene spanning parts of 
exon 1 up to intron 6 (for details see (Fuchs et al., 2001)). After homologous 
recombination in yeast the targeting construct possessed a 2 kb 5’ and 19 kb 3’ 
recombination arm for homologous recombination in ES cells. The correct assembly 
of the targeting vector was validated by enzymatic restriction analysis and 
sequencing (Fig. 14 B). 
After linearisation with NotI the targeting vector was electroporated into E14 
embryonic stem cells (provided by Prof. P. Offermanns, Institute of Pharmacology, 
University of Heidelberg, Germany) that were selected by their resistance to G418. 
The screening for correctly targeted clones was performed by Southern blot analysis. 
For Southern blot analysis genomic DNA was restricted with EcoRV and hybridised 
with the 5’ probe (Fig. 14, position of the probe) demonstrating the presence of a 10 
kb wild-type fragment and a 4.2 kb fragment specific for the targeted allele. For 
hybridisation with the CRE- and NEO probe, genomic DNA was restricted with 
EcoRV and SacI, respectively, resulting in a 6 kb and 2.2 kb fragment that was 
recognised by the NEO- and the CRE probe, respectively (Fig. 14). 
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Fig. 14 Generation of GAD67CRE/+ mice via a knock-in approach. A, B, C: Relevant features 
of the GAD67 wild-type (GAD67+/+) allele, the targeting construct and the modified 
(GAD67CRE/+) allele are illustrated. Start of the coding region in exon 1 is indicated by a black 
box, and the black diamonds stand for the two frt sites. Positions of relevant restriction 
endonuclease recognition sequences are indicated: BI: BamHI; E: EcoRV; N: NotI; S: SacI; 
SI: Sal I. D: Results of Southern blot analysis of EcoRV restricted genomic DNA obtained 
from GAD67CRE/+ and GAD67+/+ ES cells hybridised with the 5‘ probe demonstrating the 
presence of a 4.2 kb fragment specific for the modified allele (the 10 kb fragment derives 
from the wild-type allele). E: SacI restricted genomic DNA obtained from GAD67CRE/+ and 
GAD67+/+ ES cells was hybridised with the NEO probe in a Southern blot experiment 
showing a 6 kb fragment that indicates the presence of the NEO cassette. F: Southern Blot 
analysis of EcoRV restricted genomic DNA from GAD67CRE/+ and GAD67+/+ ES cells with the 
CRE probe revealed a 2.2 kb fragment corresponding to the CRErecombinase cassette. 
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3.1.3. Generation of the GAD67CRE/+ mice 
 
Two independent injections into C57Bl/6 blastocysts with ES cells derived from the 
same clone were performed by Frank Zimmermann (IBF, University of Heidelberg, 
Germany). 42 blastocysts were injected in the first round and implanted into four 
foster mothers. Five male and six female mice were born and the female offspring 
were eliminated. This is a common procedure since the used ES cells were derived 
from male embryos and thus a bias towards the male gender among chimeras was 
often observed that is reflected in phenotypic male chimera with a female genotype 
(Joyner A.L., 1993). The coat colour of the male progeny can be used to determine 
the level of chimerism since the coat colour of the mouse strain from which the ES 
cells were derived (agouti) and the one of the foster mother (black) differed. A higher 
contribution of ES cells to the germline will result in a higher proportion of agouti-
coloured coat. 
 
 
 
Fig. 15 Genotyping of GAD67CRE/+ mice by PCR analysis. A: Overview of the targeted 
GAD67 locus and the position of the oligonucleotides (YeGAD5’, 5Creup2) that were used 
for genotyping by PCR analysis. B: PCR amplification of a specific fragment (400 bp) for the 
targeted GAD67 allele from genomic tail DNA. Bp: Basepair; frt: Recognition site of flp 
recombinase; pRK5: DNA size marker; wt: Wild-type control. 
 
The first injection gave rise only to middle and low chimeric male mice and hence a 
second injection was performed. The same ES cell clone was injected into 51 
blastocysts and implanted into five foster mothers that gave birth to ten male and two 
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female mice. Out of the ten male mice eight were high and two were middle chimeric. 
From the first injection all five male mice were bred with wild-type C57Bl/6 to 
examine the offspring for germline transmission. As the offspring were born before 
the offspring of the second injection and germline transmission was successful, only 
two high chimeric males of the second injection were further bred. The progeny with 
agouti-coloured coat was genotyped by PCR analysis for the modified allele (Fig. 15) 
and positive animals were used to establish the mouse line. Mice were bred with flp-
deleter mice (Rodriguez et al., 2000) that express flippase in all cells and removes frt 
flanked fragments - here the NEO cassette (Fig. 16 A). This step was performed to 
avoid a possible influence of the NEO cassette on the expression level of the CRE 
recombinase in knock-in mice. The removal of the NEO cassette as well as the 
germline transmission of the modified allele was controlled by PCR and Southern blot 
analysis (Fig. 16 B, C). Knock-in mice with successfully removed NEO cassette were 
bred with C57Bl/6 mice to obtain a uniform genetic background.  
The inheritance of the modified allele was investigated by analysing the genotype 
and the gender from offspring derived from 21 breedings. 46 % (± 11.9 SEM) of the 
progeny (n= 147) possessed the allele with CRE recombinase and thereof 29 % were 
female and 20 % male. These results indicated that the inheritance of the altered 
allele followed the Mendelian ratio.  
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Fig. 16 Removal of the NEO cassette and confirmation by Southern blot analysis. A: The 
targeted allele before and after site-specific recombination mediated by flp-recombinase. A 
single frt site is left after the recombination. B: Southern blot analysis with EcoRV restricted 
genomic DNA obtained from GAD67CRE/+ and GAD67+/+ mice hybridised with the 5’ probe to 
confirm the germline transmission of the targeted allele (4.2 kb fragment; 10 kb fragment 
derives from the wild-type allele). C: SacI restricted genomic DNA from GAD67CRE/+;NEO/+ and 
GAD67CRE/+ mice was hybridised with the NEO probe to demonstrate that the NEO cassette 
was removed. Positions of relevant restriction endonuclease recognition sequences are 
indicated: BI: BamHI; E: EcoRV; N: NotI; S: SacI; SI: Sal I. frt: Recognition site of flp 
recombinase. 
 
3.1.4. Expression of CRE recombinase in adult GAD67CRE/+;ROSA/+ mice 
 
A reliable, frequently used approach to investigate the functionality and expression 
pattern of CRE recombinase is to breed transgenic mice expressing CRE 
recombinase with ROSA26 CRE reporter mice (R26R) (Soriano, 1999). The latter 
possess the gene encoding for β-galactosidase (lacZ) whose translation is prevented 
by an upstream floxed NEO cassette. In cells that express CRE recombinase the 
NEO cassette is excised, the lacZ gene is transcribed and its product can be 
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visualised either by a X-Gal-staining or immunohistochemically with an antibody 
against β-galactosidase. Thus GAD67CRE/+ mice lacking the NEO cassette, were bred 
with ROSA26 mice and the offspring were analysed for β-galactosidase expression. 
Figure 17 shows an overview of β-galactosidase expression in several regions of an 
adult GAD67CRE/+;ROSA/+ mouse brain that was cut coronally and stained with an anti-
β-galactosidase antibody. The expression pattern resembles the pattern that was 
expected for GAD67 expressing cells. The location of the stained cells in the 
hippocampus and the absence of staining from putative pyramidal cells indicate that 
labelled cells are interneurons (Fig. 17 B). The same holds true for the cerebral 
cortex (Fig. 17 A). Strong staining for β-galactosidase is visible in the striatum, the 
reticular thalamus as well as in the dorsomedial hypothalamic nuclei. The medial 
septum of the basal forebrain also contains β-galactosidase-positive cells (Fig. 17 C - 
F). The expression of β-galactosidase in the cerebellum can be detected in Purkinje 
cells as well as in some cells in the molecular and granular cell layer that are 
presumably basket/stellate or Golgi cells, respectively. Furthermore some strongly 
labelled cells are located in the deep cerebellar nuclei (Fig. 17 G). 
In the olfactory bulb, most cells in the periglomerular and granular cell layer are 
intensely stained for β-galactosidase. Few labelled cells are found in the external 
plexiform layer and in the accessory olfactory bulb (Fig. 17 H). These results indicate 
that CRE recombinase is functional under the control of the GAD67 promoter in vivo 
and can thus be used to ablate floxed genes of interest.  
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Fig. 17 Distribution of β-galactosidase-expressing cells in the adult brain of a 
GAD67CRE/+;ROSA/+ mouse. A-H: Immunohistochemical experiments were performed with an 
anti-β-galactosidase antibody (coronal sections) and the resulting expression pattern of β-
galactosidase in several brain regions are shown: the cerebral cortex (A), the hippocampus 
(B), the striatum and the reticular thalamus (C), the basolateral amygdala (D), the 
hypothalamic region (E), the septal region (F), the cerebellum (G) and the olfactory bulb (H). 
3V: Third ventricle; AOB: Accessory olfactory bulb; BLA: Basolateral amygdala; Ctx: Cortex; 
CPu: Striatum; DCN: Deep cerebellar nuclei; DG: Dentate gyrus; DM: Dorsomedial 
hypothalamic nucleus; GCL: Glomerular cell layer; GR: Granule cell layer; Rt: Reticular 
thalamus; LS: Lateral septum; Mol: Molecular cell layer; MS: Medial septum; WM: White 
matter; ZI: Zona incerta. Scale bar: 250 µm. 
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3.1.5. CRE recombinase expressing cells in the brain of GAD67CRE/+;ROSA/+ mice 
 
Since the labelling for β-galactosidase only provides information about the location of 
expression but not whether these cells are GAD67-positive cells, a more thorough 
analysis had to be performed. Thus double-labelling experiments including a X-Gal-
staining and an immunhistochemical staining for GAD67 were performed and 
evaluated. Two male and two female GAD67CRE/+;ROSA/+ mouse brains (adult, at least 
8 weeks) were cut coronally (50 µm) and on every fourth section double labelling 
experiments were performed. The analysed regions were the hippocampus 
subdivided in the subregions: CA1, CA3 and dentate gyrus (without granular cell 
layer), and two cortical areas: motor cortex and somatosensory cortex (Fig. 18). 
Areas of 46 mm2 in size from 10 sections per brain were investigated and the mean 
value was determined followed by calculating the overall mean of all four brains. 
The results are summarised in Tab. 1. In each subregion of the hippocampus around 
50% of analysed cells were double-positive for β-galactosidase and GAD67. The 
remaining 50% (approximately) were positive only for β-galactosidase. A similar 
result is found in the motor and the somatosensory cortex, about half of all analysed 
cells were double-labelled whereas the other half was positive for β-galactosidase 
but not for GAD67. No differences between female and male brains were detected. 
 
Tab. 1 Analysis of β-galactosidase- positive cells in the GAD67CRE/+;ROSA/+ mouse. 
 
Data are indicated as the mean ± SEM values and were obtained from four adult 
GAD67CRE/+;ROSA/+ mice. β-gal: β-galactosidase. 
1137
1207
994
1157
1028
n = 
analysed cells
52.4 ± 6.0  
50.6 ± 6.5
47.3 ± 5.9
49.5 ± 7.4
Cortex
Motor
Somatosensory
49.5 ± 5.8
48.1 ± 6.7
44.6 ± 4.6
50.2 ± 6.1
51.8 ± 6.9
55.3 ± 4.6
Hippocampus
DG
CA3
CA1
β-gal 
positive cells (%)
β-gal & GAD67 
positive cells (%)
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Fig. 18 Analysis of cells expressing β-galactosidase within distinct brain regions of the 
GAD67CRE/+;ROSA/+ mouse. Coronal sections were co-stained for β-galactosidase (blue) and 
GAD67 (brown) using X-Gal- and immunohistochemical staining methods, respectively. A: 
Overview of a coronal section. B-G: Higher magnifications of the marked areas in A (boxes). 
C: CA1 region. D: CA3 region. E: Dentate gyrus, the inset shows an example of a double-
labelled cell. F: Motor cortex. G: Somatosensory cortex. CPu: Striatum; DG: Dentate gyrus; 
Ent: Entorhinal cortex; Hi: Hippocampus; M: Motor cortex; S: Somatosensory cortex; s.o.: 
Stratum oriens; s.p.: Stratum pyramidale; s.r.: Stratum radiatum. Scale bars: 250 µm (B), 25 
µm (C-G). 
 
To further validate the expression of CRE recombinase in GAD67-positive cells, 
double-labelling experiments with combinations of an anti-β-galactosidase antibody 
and antibodies against several interneuronal markers - parvalbumin, calbindin and 
somatostatin - were performed (Fig. 19). The experiments were performed on 
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sections obtained from three adult GAD67CRE/+;ROSA/+ mice (male and female). 
Labelled cells of two sections from each mouse were counted and the mean value 
was calculated. In Tab. 2 the results are listed. Almost all cells in the hippocampus 
and the cortex were double-positive for β-galactosidase and parvalbumin. The 
double-labelling experiment with β-galactosidase and calbindin showed as well a 
nearly complete overlap in the hippocampus. In the motor and somatosensory cortex 
the percentage of double-positive cells was around 90%. All cells of the hippocampus 
were co-labelled for β-galactosidase and somatostatin. More than 90 % of all counted 
cells in the cortical areas exhibited an overlapping signal.  
These results convincingly demonstrated that specific gene ablation in all GAD67-
expressing cells can be obtained utilizing GAD67CRE/+ mice. 
 
Tab. 2 Characterisation of β-galactosidase-expressing cells in the GAD67CRE/+;ROSA/+  mouse. 
 
Data are indicated as the mean ± SEM values and were obtained from three adult 
GAD67CRE/+;ROSA/+ mice. β-gal: β-galactosidase; CB: Calbindin; PV: Parvalbumin; SOM: 
Somatostatin. 
93 ± 1.4 (111)
92 ± 3.2 (94)
100 ± 0     (60)
100 ± 0     (33)
100 ± 0 (40)
β-gal & SOM 
positive cells (%)
(n)
92 ± 5.1  (38)
88 ± 8     (43)
99 ± 1.3 (97)
96 ± 3.1 (70)
Cortex
Motor
Somatosensory
100 ± 0      (3)
95 ± 6.2   (13)
92 ± 11.1 (9)
96 ± 5.3 (29)
100 ± 0    (46)
100 ± 0    (43)
Hippocampus
DG
CA3
CA1
β-gal & CB 
positive cells (%)
(n)
β-gal & PV 
positive cells (%)
(n)
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Fig. 19 Interneuronal markers are co-expressed in β-galactosidase-positive cell in the 
hippocampus and the cortex. A, D: Immunolabelling for β-galactosidase (green) and 
parvalbumin (red). B, E: Double-immunohistochemical experiments with an anti-β-
galactosidase antibody (green) and an anti-calbindin antibody (red). C, F: Co-labelling of β-
galactosidase (green) and somatostatin-positive cells (brown, DAB immunohistochemical 
staining). Cells marked with an arrow serve as examples for double-positive cells (yellow). β-
gal: β-galactosidase; CB: Calbindin; SOM: Somatostatin; s.o.: Stratum oriens; s.p.: Stratum 
pyramidale; PV: Parvalbumin. Scale bar: 25 µm. 
 
3.1.6. Expression of CRE recombinase in embryonic GAD67CRE/+;ROSA/+ mice 
 
The demonstration of the functionality of CRE recombinase in embryonic mice is a 
prerequisite to plan experiments that address developmental questions. By analysing 
embryonic day (E) 16 offspring resulting from the breeding of GAD67CRE/+ mice with 
R26R reporter mice, the functionality of CRE recombinase could be demonstrated by 
X-Gal staining experiments. In sagital (whole embryo) as well as in coronal sections 
(head) the staining pattern of CRE recombinase expression resembled the known 
expression pattern for GAD67. There was staining in the embryonic brain in the 
olfactory bulb, the cerebral neocortex, the developing hippocampal formation, the 
thalamic regions, the midbrain and the cerebellum (Fig. 20 A-E). The labelled cells in 
the cerebral neocortex and the hippocampus were mainly located in the cortical plate 
and subventricular zone with some scattered cells in the intermediate zone (Fig. 20 
D, E). Labelled cells were also detected in the dorsal and ventral horn of the spinal 
cord (Fig. 20 A, I). In addition, stained cells were observed in non-neuronal tissues, 
such as in the developing fore- and hindlimbs, the mesenchyme and neuroepithelium 
of the tailbud, the vibrissae and the kidney (Fig. 20 F-J). 
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Fig. 20 Expression pattern of β-galactosidase in embryonic GAD67CRE/+;ROSA/+ mice. X-Gal 
staining experiments (blue colour) were performed on sagital (A-C, F-J) and coronal sections 
(D, E) of GAD67CRE/+;ROSA/+ mice at embryonic day 16. A: Overview of an E16 embryo. B: 
Higher magnification of the forebrain. C: Higher magnification of the midbrain, the cerebellum 
and the medulla oblongata. D: Overview of the neocortex with its distinct layers: cortical 
plate, subventricular zone and neuroeptihelium. E: Overview of the developing hippocampus. 
F: Expression of β-galactosidase in the vibrissae. G: β-galactosidase positive cells in 
forelimb. H: Stained cells in the hindlimb. I: β-galactosidase labelled cells in the kidney and in 
the spinal cord. J: Expression of β-galactosidase in the tailbud. The red colour in A-C and F-J 
derived from counterstaining of the sections with Neutral Red. Cb: Cerebellum; CP: Cortical 
Plate; CPu: Striatum; Ctx: Cortex; H: Hypothalamus; Is: Isthmus; MB: Midbrain; NE: 
Neuroepithelium; OB: Olfactory bulb; P: Pons; SVZ: Subventricular zone; Sc: Spinal cord; T: 
Thalamus. Scale bars: A: 0.25 cm; B-J: 250 µm. 
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3.1.7. The GAD67 promoter of GAD67CRE/+ mice is not active in gametes 
 
Analysis of GAD67CRE/+;ROSA/+ mice included experiments that address whether the 
promoter driving the CRE recombinase is already active in the gametes of the 
mouse. If this was the case, cell-type specific gene ablation would not be possible. 
To this end GADCRE/+;ROSA/+ mice were bred with wild-type C57Bl/6 mice and the 
offspring were analysed concerning their ability to express β-galactosidase. X-Gal 
staining was performed on sections of these mice as well as on control sections 
(derived from GAD67CRE/+;ROSA/+) and staining for β-galactosidase was detected only 
on the control sections (data not shown). This result indicated that CRE recombinase 
is not active in gametes and the mice can be used to generate gene knock-outs in 
GAD67 expressing cells only. 
 
3.1.8. Preliminary results of the behavioural analysis of GAD67CRE/+ mice 
 
The behavioural tests were performed to exclude phenotypic deficits of GAD67CRE/+ 
mice due to reduced expression level of GAD67 deriving from the modified allele that 
is not expressing the GAD67 gene anymore. The tests were performed by Dr. Elke 
Fuchs (Department of Clinical Neurobiology, University of Heidelberg, Germany) on 
adult GAD67CRE/+ mice and their wild-type littermates as control animals.  
The results of the behavioural tests can only be considered as preliminary since the 
number of tested animal was too low. For behavioural studies (Crawley, 2000) at 
least 15 animals of the same gender (male) should be tested to reduce the influence 
of an individual performance of one animal on statistics. GAD67CRE/+ mice were 
indistinguishable from wild-type mice upon visual inspection.  
To analyse motor learning ability of GAD67CRE/+ mice, the accelerating rotarod test 
was performed on three consecutive days (= three blocks) with three trials per mouse 
on each day. GAD67CRE/+ mice were able to learn the task but, as mentioned above, 
to conclusively answer the question more animals have to be tested (Fig. 21 A). No 
impairment in the explorative behaviour of the GAD67CRE/+ mice was observed during 
the open field test (Fig. 21 B). There were neither significant differences in the 
squares that GAD67CRE/+ and control mice crossed nor in the number of rearings on 
both days of the testing. Furthermore the novel object recognition test also did not 
reveal differences in the explorative behaviour of GAD67CRE/+ mice (Fig. 21 C). 
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Fig. 21 Preliminary behavioural tests with GAD67CRE/+ mice. A: Rotarod test. GAD67CRE/+ and 
wild-type mice performed equally well on three consecutive days (three trials per day) in the 
accelerated rotarod motor test. (wt n= 6; GAD67CRE/+ n= 6). B: Open field test. GAD67CRE/+ 
mice performed similarly compared to control animals. The test was performed twice on two 
consecutive days. (wt n= 7; GAD67CRE/+ n= 6). C: Novel object recognition test. GAD67CRE/+ 
mice showed no differences in recognising a new object compared to the wild-types. The test 
was performed five minutes after a five minutes training phase. In the training phase the 
mouse was allowed to explore two different objects (A and B). The bars show the time spent 
with the objects. During the retention phase object B was exchanged with object C and the 
time spent with the objects was measured again. (wt n= 6; GAD67CRE/+ n= 6). Each column 
represents the mean ± SEM. 
 
3.1.9. Decreased GAD67 protein expression levels in GAD67CRE/+ mice 
 
GAD67CRE/+ mice and their wild-type littermates that were used for behavioural tests 
(3.1.8.) were subsequently used to investigate the GAD67 protein levels in forebrains 
of GAD67CRE/+ mice. Total protein of forebrains from five GAD67CRE/+ mice and five 
wild-type control mice were prepared and were analysed in triplicates by Western 
blot analysis (Fig. 22). The ECL-stained Western blot films were scanned and the 
intensity of the detected signals for GAD67 as well as the β-actin as a control, were 
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determined with the ImageJ program (from the National Institute of Health, Maryland, 
USA). The quantification was performed by normalising the value for GAD67 to β-
actin and calculating the mean value of each triplicate. The reduction of GAD67 
protein expression in each pair and the overall mean from all pairs was determined. 
This value revealed a reduction of GAD67 protein expression in GAD67CRE/+ mice to 
48.5% (± 15 SEM) compared to wild-type mice. In one GAD67CRE/+ mouse the 
GAD67 protein level was reduced to 26% compared to wild-type expression levels 
accounting for the high SEM. 
 
 
 
Fig. 22 Reduced GAD67 protein expression in GAD67CRE/+ mice. The GAD67 protein levels 
of five GAD67CRE/+ mice and five wild-type littermates were quantified by measuring the 
intensity of the Western blot signal with the ImageJ program from the NIH. The analysis 
revealed that the GAD67 protein expression in GAD67CRE/+ mice is half of the expression 
levels detected in wild-type mice. 
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3.2. Generation and analysis of the SOMCRE/+ mouse line 
 
3.2.1. Expression pattern of the somatostatin gene in the developing and 
mature mouse brain 
 
In situ hybridisation (ISH) experiments with radioactive labelled oligonucleotides were 
performed to investigate the regional distribution of the somatostatin gene during 
development. Three different oligonucleotides for the somatostatin gene were chosen 
to compare the expression pattern and thus control the specificity.  
ISH experiments were performed on horizontal mouse brain sections at embryonic 
day (E) 14, postnatal days (P) 1, 9, 15, 25 and in the adult. The three 
oligonucleotides showed similar expression patterns with different intensities of the 
ISH signal and corresponded with the results of former publications. Images from the 
ISH experiment with highest signal intensity are shown in Figure 23. 
 
 
 
Fig. 23 Expression of somatostatin mRNA in the developing and mature mouse brain. The 
spatial and temporal distribution of somatostatin mRNA was determined by radioactive in situ 
hybridisation experiments on embryonic (E14; sagital) and postnatal (P1, P9, P15, P25 and 
adult; horizontal) mouse brain sections. The inset illustrates a higher magnification of the 
hippocampus. Hi: Hippocampus; Ctx: Cortex; Cpu: Striatum; IC: Inferior colliculus; Rt: 
Reticular thalamus. Scale bar: 0.5 cm. 
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Preprosomatostatin mRNA is expressed already at high levels at E14 and was 
restricted to the central nervous system. At postnatal stages (P1-adult), mRNA 
expression was detected throughout all layers of the cerebral cortex, the striatum, the 
reticular thalamus and the hippocampus with a more intense signal in the CA1 region 
(Fig. 23, P9, inset). A strong signal was visible in the inferior colliculus already at E14 
and was also visible on the section from the P9 mouse brain.  
There was hardly any mRNA expression detectable in the olfactory bulb in contrast to 
the accessory olfactory bulb where some expression was detected (Fig. 23, P15). No 
expression was found in the cerebellar cortex. 
 
3.2.2. Construction of the targeting vector 
 
The somatostatin gene comprises two exons and the startcodon is located in exon 
one. The strategy for generating mice expressing CRE recombinase under the 
promoter of somatostatin was to replace the translational startcodon of somatostatin 
by the one of CRE recombinase. 
A detailed description of the cloning strategy is shown in Fig. 25. A 10 kb fragment of 
the BAC 220B24 containing the somatostatin locus was subcloned into pBluescript 
SK+ (pBS) via shotgun-cloning (Fig. 24). Shortly, the BAC DNA and the pBS DNA 
were digested with BamHI, ligated and transformed into E.coli bacteria. The resulting 
colonies were lifted on a membrane that subsequently was hybridised with a 32P-
labeled 3’probe to identify colonies containing the somatostatin locus. Thus, one 
positive clone contained the somatostatin locus including 3 kb upstream and 7 kb 
downstream that were used as recombination arms (RA) for homologous 
recombination in ES cells (pBS-SOM). 
For building the targeting construct, pBS was used as a vector and it consisted of the 
following components: a CRE recombinase cassette encoding the recombinase of 
phage P1 (subcloned from pMC-CRE recombinase, (Gu et al., 1993)). Downstream a 
cassette was introduced containing the neomycin resistance gene (neomycin 
phosphotransferase, NEO) with its own promoter (derived from the herpes simplex 
virus) for negative selection in ES cell culture. The NEO cassette was flanked by frt 
sites. The original NEO cassette was from Cope et al. and was modified by Dr. Irinel 
Coserea by removing the loxP site and subcloning it to Lit29 (Cope et al., 2004). The 
targeting construct itself was flanked by a 5’ and 3’ recombination arm (RA, 280 and 
260 bp, respectively) to introduce it into the correct position of the somatostatin gene 
 49 
  3. Results 
(Fig. 25 D). The correct assembly of the targeting construct (pBS-SOM/TG) was 
confirmed by enzymatic restriction analysis and by sequencing. 
 
 
 
Fig. 24 Subcloning of a fragment of BAC 220B24. A 10 kb fragment containing both exons of 
the somatostatin gene was subcloned utilising the shotgun cloning method into pBS. Both 
the BAC and pBS were restricted with BamHI, ligated and transformed into E.coli. The 
resulting colonies were screened with a 32P-labeled 3’ probe for clones possessing a BAC 
fragment including the somatostatin gene. 
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Fig. 25 Strategy for cloning of the targeting construct. A: Subcloning of the CRE 
recombinase cassette in pBluescript and cloning of the 5’RA resulting in pBS-CRE-5’. B: 
Adding the 3’RA to pBS-CRE-5’ by cloning the RA (3’*) of another construct including one frt 
site and exchanging the old RA with the new 3’RA (pBS-CRE-5/3). C: Cloning of the NEO-
cassette into pBS-CRE-5/3 (pBS-Tg). D: Cloning of the targeting cassette into the startcodon 
of the somatostatin gene that was included in the vector pBS-SOM obtained from the 
shotgun-cloning experiment (Fig. 24). Relevant restriction endonuclease recognition sites are 
indicated: AIII: AflIII; BI: BamHI; B: BglI; EI: EcoRI; EV: EcoRV; K: KpnI; N: NotI; S: SalI; X: 
XhoI. RA: Recombination arm; frt: Recognition site of flp recombinase. The constructs are 
not drawn to scale. 
 
 51 
  3. Results 
3.2.3. Selection of targeted ES cell clones 
 
The targeting construct pBS-SOM/Tg was linearised with NotI and electroporated into 
mouse embryonic stem cells derived from the ES cell line R1 (Nagy et al., 1993). ES 
cell clones were selected based on their resistance to G418 guaranteed by the NEO 
cassette present in the targeting construct. 960 G418-resistant clones were picked 
and 360 were further screened for the correct targeting event by Southern blot 
analysis. 
EcoRV restricted genomic DNA obtained from these clones was hybridised with the 
external 5’ probe (Fig. 26 C, position of the probe) demonstrating either the presence 
of a 10 kb fragment derived from the wild-type allele or both a 10 kb ‘wild-type’ 
fragment and a 5.8 kb fragment that is specific for the modified allele. Nine clones 
showed the expected signal with the 5’probe for a correct targeting event via 
homologous recombination. 
Six of these clones were further analysed by Southern blot analysis with the 3’-, 
NEO- and CRE probe (Fig. 26 E-G). In three clones the correct targeting was 
demonstrated by the specific fragment sizes: one fragment larger than 10 kb (wild-
type allele) and a 6.9 kb fragment (modified allele) detected with the 3’ probe; one 
1.2 kb and one 1 kb fragment detected with the NEO and the CRE probe, 
respectively. 
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Fig. 26 Generation of SOMCRE/+ mice via a knock-in approach. A, B, C: Relevant features of 
the somatostatin wild-type allele (SOM+/+), the targeting construct and the modified 
(SOMCRE/+) allele are shown. Start of the coding region in exon 1 is indicated by a black box, 
and the black diamonds stand for the two frt sites (recognition site of flp recombinase.). 
Positions of relevant restriction endonuclease recognition sequences are indicated: A: AgeI; 
B: BamHI; E: EcoRV; N: NotI as well as the locations of the used probes. D: Southern blot 
analysis of EcoRV restricted genomic DNA from SOMCRE/+ and SOM+/+ ES cells hybridised 
with the 5‘ probe demonstrating the presence of a 5.8 kb fragment specific for the modified 
allele (the 10 kb fragment derives from the wild-type allele). E: BamHI restricted genomic 
DNA obtained from SOMCRE/+ and SOM+/+ ES cells was analysed by Southern blot 
experiments with the 5’ probe and resulted in a 6.9 kb and a > 10 kb fragment for the 
modified and the wild-type allele, respectively. F: EcoRV restricted genomic DNA obtained 
from SOMCRE/+ and SOM+/+ ES cells was hybridised with the CRE probe in a Southern blot 
experiment showing a 1 kb fragment indicating the presence of the CRE cassette. G: 
Southern blot analysis of EcoRV restricted genomic DNA from SOMCRE/+ and SOM+/+ ES cells 
with the NEO probe revealed a 1.2 kb fragment corresponding to the NEO cassette. 
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3.2.4. Generation of SOMCRE/+ mice 
 
One of the three positive ES cell clones was injected into 45 C57Bl/6 mouse 
blastocysts that were transferred into four foster mothers (the injection was 
performed by Frank Zimmermann, IBF, University of Heidelberg, Germany). Twelve 
male and ten female mice were born and the female offspring were eliminated. The 
chimeric level of the male mice were determined as previously described in chapter 
3.1.3.. Out of the twelve male mice, two were high, seven middle and three low 
chimeric. The two high and three middle chimeric mice were bred with C57Bl/6 mice 
to determine germline transmission of the altered allele (Fig. 27). The offspring of the 
breeding was again investigated for the coat colour and all agouti-coloured mice 
were genotyped by DNA tail analysis (Fig. 28). Mice positive for the modified 
somatostatin allele were bred with flp-deleter mice (Rodriguez et al., 2000) to remove 
the NEO cassette. Subsequently SOMCRE/+ mice without the NEO cassette were bred 
with C57Bl/6 mice to propagate the line and to increase the C57Bl/6 genetic 
background (Fig. 29). 15 litters were analysed taking into consideration the 
inheritance of the modified allele. From 34 % (± 11.2 SEM) of mice positive for CRE 
recombinase (n= 115), 15 % were female and 20 % male, indicating that the 
inheritance of the modified allele follows the Mendelian pattern. 
Germline transmission as well as the removal of the NEO cassette was additionally 
confirmed by Southern blot analysis with the 5’-, 3’- and NEO probe (Fig. 29 C-E). 
 
 
 
Fig. 27 Chimeric SOMCRE/+ mice. The coat colour of the male progeny can be used to 
determine the chimeric level since the coat colour of the mouse strain from which the ES 
cells were derived (R1, agouti) and the one of the foster mother (C57Bl/6, black) differed. A 
higher contribution of ES cells to the germline will result in a higher proportion of agouti-
coloured coat. 
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Fig. 28 Genotyping of SOMCRE/+ mice by PCR analysis. A: Overview of the targeted SOM 
locus and position of the oligonucleotides (5’Tg for, 5Creup2) that were used for genotyping 
by PCR analysis. B: PCR amplification of a fragment (391 bp) that is specific for the targeted 
SOM allele using genomic tail DNA. Bp: Basepair; frt: Recognition site of flp recombinase; 
pRK5: DNA size marker; wt: Wild-type control. 
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Fig. 29 NEO-cassette removal and validation by Southern blot analysis. A: Breeding scheme 
for removal of the NEO cassette. SOMCRE/+;NEO/+ mice were bred with flp-deleter mice 
(Rodriguez et al., 2000) that is able to promote site-specific recombination of floxed 
fragments by expressing flp recombinase. B: The modified allele with and without the NEO 
cassette. C, D: Southern blot analysis of EcoRV (EV) and BamHI (BI) restricted genomic 
DNA of SOMCRE/+ mice with the 5’ and 3’ probe, respectively, to confirm germline 
transmission of the modified allele. E: Confirmation of the recombination of the NEO cassette 
by Southern blot analysis of EcoRV restricted genomic DNA obtained from SOMCRE/+;NEO/+ 
and SOMCRE/+ mice. frt: Recognition site of flp recombinase. 
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3.2.5. CRE recombinase expression in adult SOMCRE/+;ROSA/+ mouse brains 
 
SOMCRE/+ mice without the NEO cassette were bred with mice of the ROSA26 CRE 
reporter line (Soriano, 1999) to investigate the functionality of CRE recombinase 
under the somatostatin promoter and to monitor the expression pattern. The 
ROSA26 mice contain a floxed NEO cassette that keeps a lacZ gene inactive. In 
cells containing CRE recombinase NEO is excised, the lacZ gene that encodes for β-
galactosidase is transcribed and β-galactosidase can be visualised either with an 
anti-β-galactosidase antibody staining or a X-Gal stain.  
In Fig. 30 an overview of β-galactosidase expression in several regions of an adult 
SOMCRE/+;ROSA26/+ mouse brain is shown. This staining indicated that the CRE 
recombinase is able to mediate site-specific recombination of loxP sites and thus 
removes floxed genes of interest in vivo. The localisation of the stained cells in the 
hippocampus resembled the known expression pattern of somatostatin: most of the 
β-galactosidase-positive cells were located in the stratum oriens of the CA3 and CA1 
regions and some in the hilus of the dentate gyrus (Fig. 30 B). The cortex showed β-
galactosidase staining that was homogeneously distributed in all layers (Fig. 30 A). 
Only few β-galactosidase expressing cells were located in the striatum (Fig 30 C). 
The reticular thalamus demonstrated an intense labelling (Fig. 30 D). Strong staining 
was also visible in the central amygdaloid nuclei in contrast to the lateral and 
basolateral amygdala (Fig. 30 E). In the lateral hypothalamic area as well as the zona 
incerta of the thalamus some β-galactosidase positive cells were located (Fig. 30 F). 
The same applied to the medial and lateral septum (Fig. 30 G). 
The cerebellar cortex showed labelling for β-galactosidase of some Purkinje cells as 
well as of some cells in the granular cell layer - presumably Golgi cells - and the 
molecular layer (Fig. 30 H, I). In addition a strong staining was also detected in the 
deep cerebellar nuclei (Fig. 30 I). The olfactory bulb demonstrated only very weak 
staining of a few cells in the glomerular cell layer (data not shown). 
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Fig. 30 Localisation of β-galactosidase expression in the SOMCRE/+;ROSA/+ mouse brain. 
Immunohistochemistry with an anti-β-galactosidase antibody demonstrated the expression of 
β-galactosidase in different regions of an adult SOMCRE/+;ROSA/+ mouse brain (coronal 
sections). Pictures show overviews of A: Cerebellar cortex. B: Hippocampus. C: Striatum. D: 
Reticular thalamus. E: Basolateral and central amygdala. F: Hypothalamic region. G: Septal 
area. H, I: Cerebellum. Arrows in highlight examples of β-galactosidase-expressing cells. 
BLA: Basolateral amygdala; CeA: Central amygdala; Ctx: Cortex; CPu: Striatum; DCN: Deep 
cerebellar nuclei; DG: Dentate gyrus; GR: Granule cell layer; Rt: Reticular thalamus; LH: 
Lateral hypothalamic area; LS: Lateral septum; Mol: Molecular cell layer; MS: Medial septum; 
Subl: Subincertal Nucleus. Scale bars: 150 µm (C, D); 250 µm (A, B, E-I). 
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3.2.6. Analysis of CRE-expressing cells in the SOMCRE/+;ROSA/+ mouse brain  
 
For more detailed analysis three brains of adult (at least 8 weeks old) SOMCRE/+;ROSA/+ 
male mice were cut coronally (50 µm) in serial sections and on every fourth section a 
double-labeling experiment was performed consisting of a X-Gal staining followed by 
a immunohistochemical staining for somatostatin-positive cells. The analysed areas 
were the hippocampus subdivided in the CA1, CA3 region and the dentate gyrus as 
well as  three cortical regions: motor-, somatosensory- and entorhinal cortex, and the 
striatum (Fig. 31). For each region cells within an area of 46 mm2 were counted and 
the mean value of all sections from one brain was calculated. The results of all 
analysed brains were summarised by defining the overall mean value (Tab. 3). In the 
hippocampus the percentage of cells co-expressing β-galactosidase and 
somatostatin showed great variance among the different areas of the hippocampus. 
with between 25% in the CA3 region and around 60% in the CA1 region. The cells 
that show no co-labelling are either only somatostatin-positive (29 - 67% depending 
on the hippocampal area) or only β-galactosidase-positive (2 - 17%). 
 
Tab. 3 Analysis of β-galactosidase-positive cells in the SOMCRE/+;ROSA/+ mouse. 
 
Data are indicated as the mean ± SEM values and were obtained from three adult 
SOMCRE/+;ROSA/+ mice. β-gal: β-galactosidase; SOM: Somatostatin.  
64.0 ± 6.5
45.9 ± 2.0
66.7 ± 4.1
66.9 ± 4.3
58.1 ± 2.7
29.6 ± 4.4
SOM
positive cells 
(%)
492
452
231
766
533
642
n = 
analysed 
cells
1.6 ± 0.7  
2.2 ± 0.6
0.4 ± 0.5
34.4 ± 7.6
52.7 ± 1.9
33.1 ± 3.6
Cortex
Motor
Somatosensory
Striatum
2.9 ± 1.1
16.8 ± 4.5
10.0 ± 4.6 
30.4 ± 5.6
25.1 ± 3.3
60.2 ± 4.4
Hippocampus
DG
CA3
CA1
β-gal 
positive cells
(%)
β-gal & SOM 
positive cells
(%)
 
For the evaluated cortical regions the percentages of cells double-labelled for both 
markers were as well not consistent either. In the motor cortex over 30% of all 
analysed cells were double-positive and 64% were only positive for somatostatin. In 
the somatosensory cortex approximately 50% were double-labelled. In the striatum 
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around 30% showed β-galactosidase and somatostatin staining and more than 60% 
expressed only somatostatin. The percentages of cells expressing β-galactosidase 
only is very low (0.4 - 2.2%). 
These results allow the conclusion that in SOMCRE/+ mice the removal of floxed genes 
is possible but it does not occur in all somatostatin-expressing cells. The incomplete 
removal has to be taken into consideration in mice aiming at functional analysis after 
deletions of specific genes. 
 
 
 
Fig. 31 Analysis of the β-galactosidase-positive cells in different brain areas in 
SOMCRE/+;ROSA/+ mice. Double-labelling experiments including a X-Gal staining (blue) followed 
by immunolabelling for somatostatin (brown) were performed on coronal sections of adult 
SOMCRE/+;ROSA/+ mice indicating that not all somatostatin-expressing cells also express β-
galactosidase. A: Overview of a coronal section illustrates the analysed areas (boxed). B-H: 
Higher magnifications of the examined areas. B: CA1 region. The inset shows a cell 
expressing both β-galactosidase and somatostatin. C: Dentate gyrus. D: CA3 region. E: 
Motor cortex. F: Somatosensory cortex. G: Entorhinal cortex. H: Striatum. Arrows indicate 
examples for double-labelled cells. CPu: Striatum; DG: Dentate gyrus; Ent: Entorhinal cortex; 
Hi: Hippocampus; M: Motor cortex; S: Somatosensory cortex; s.o.: Stratum oriens; s.p.: 
Stratum pyramidale; s.r.: Stratum radiatum. Scale bar: 25 µm. 
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3.2.7. CRE recombinase expression in embryonic SOMCRE/+;ROSA/+ mice 
 
Since the expression of the endogenous somatostatin gene starts as early as 
embryonic day 7.5 (Gittes and Rutter, 1992) it was important to show that CRE 
recombinase in prenatal SOMCRE/+ mice is functional and the expression pattern 
corresponds with the endogenous one. X-Gal staining experiments of 
SOMCRE/+;ROSA/+ mice at embryonic day (E) 15 showed that CRE recombinase is 
expressed in cells of the neocortex, the hypothalamus, the midbrain, the cerebellum 
and the pons as well as the medulla oblongata (Fig. 32). In the neocortex labelled 
cells were mainly located in the cortical plate and a few in the intermediate zone (Fig. 
32 C, D). The spinal cord showed labelling in both the dorsal and ventral horn with a 
more prominent labelling in the latter (Fig. 32 H). Furthermore, staining was detected 
in the dorsal root ganglia and the trigeminal ganglion (Fig. 32 E, F). Stained cells 
were additionally detected in non-neuronal tissues, such as the teeth, the midgut and 
in the kidney as well as the adrenal gland (Fig. 32 G, I, J). In summary, these results 
indicated that CRE recombinase is already promoting site-specific recombination 
during early prenatal development. 
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Fig. 32 Localisation of β-galactosidase expression in embryonic SOMCRE/+;ROSA/+ mice. X-Gal 
staining experiments (blue colour) of coronal (C, D) and sagital (A, B, E - J) sections of 
SOMCRE/+;ROSA/+ mice at embyronic day (E) 15. A: Overview of the central nervous system. B: 
Higher magnifications of the dorsal brain. C: Overview of the neocortex with labelled cells 
located mainly in the cortical plate. D: Higher magnification of the cortical plate. Arrows 
indicate β-galactosidase-positive cells. E: Expression of β-galactosidase in the dorsal root 
ganglia. F: β-galactosidase labelled cells in the trigeminal ganglion. G: X-Gal staining of the 
teeth. H: Expression of β-galactosidase in the spinal cord, with a higher number of labelled 
cells in the ventral horn. I: β-galactosidase stained cells in the midgut. J: Expression of β-
galactosidase in cells of the kidney and the adrenal gland. The red colour of the sections in E 
- G derived from counterstaining with Neutral Red. AG: Adrenal gland; Cb: Cerebellum; C: 
Cochlea; CP: Cortical plate; DH: Dorsal horn; DRG: Dorsal root ganglion; Gn: Trigeminal 
ganglion; Is: Isthmus; LV: Lateral ventricle; M: Medulla; MB: Midbrain; P: Pons; T: Thalamus; 
VH: Ventral horn. Scale bars: A: 1 mm; B: 500 µm; C: 125 µm; D: 25 µm; E - J: 250 µm. 
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3.2.8. Misexpression of CRE recombinase in pyramidal cells of the 
hippocampus  
 
The analysis of the co-expression of β-galactosidase and somatostatin revealed the 
labelling of additional β-galactosidase-positive cells in the pyramidal cell layer of the 
hippocampus (Fig. 33 A). These cells were mainly located in the CA1 region. Double-
labelling experiments with interneuronal markers such as parvalbumin and GAD67 
were performed to gain more information about their identity. None of the markers 
was expressed in the β-galactosidase-positive cells (Fig. 33). Based on the location, 
the shape of the soma and the position of the neurites, it can be concluded that these 
cells are possibly pyramidal cells and that CRE recombinase is misexpressed in 
these cells. 
 
 
 
Fig. 33 Cells positive for β-galactosidase in the pyramidal cell layer of the hippocampus do 
not express interneuronal markers. A: A representative image of a double-labelling for β-
galactosidase (blue) and somatostatin (brown) is shown and no co-localisation of both 
stainings was detected in the pyramidal cell layer. B: Immunohistochemical staining of the 
pyramidal cell layer with an anti-β-galactosidase antibody (green). C,D: Further double-
labelling experiments with antibodies against β-galactosidase (green) and parvalbumin (C; 
red) or GAD67 (D; red) were performed and they showed no overlapping expression. 
Parvalbumin- and GAD67-positive cells are pointed out with asterisks. E: High magnification 
of a β-galactosidase positive cell in the pyramidal cell layer. The arrows mark the neurites of 
the cell. β-gal: β-galactosidase; SOM: Somatostatin; s.o.: Stratum oriens; s.p.: Stratum 
pyramidale; s.r.: Stratum radiatum; PV: Parvalbumin. Scale bars: 25 µm. 
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3.2.9. The somatostatin promoter in SOMCRE/+ mice is not active in gametes 
 
The aim of the SOMCRE/+ mouse line is to selectively ablate genes in somatostatin-
positive cells hence it had to be investigated whether the somatostatin promoter is 
already active in the gametes. Expression of CRE recombinase in the gametes would 
affect additional cell populations and thus impedes the generation of cell-type specific 
knock-out mice. SOMCRE/+;ROSA/+ mice were bred with C57Bl/6 mice and the offspring 
genotyped positively only for β-galactosidase were further analysed. X-Gal stainings 
were performed on sections of β-galactosidase-positive (SOM+/+;ROSA/+) and control 
mice (SOMCRE/+;ROSA/+). No staining for β-galactosidase was detected on sections of 
the SOM+/+;ROSA/+ mice (Fig. 34). Hence, it is possible to generate cell-type specific 
knock-outs with SOMCRE/+ mice. 
 
 
 
Fig. 34 The somatostatin promoter is not active in the gametes. X-Gal stainings were 
performed on sections of a SOMCRE/+;ROSA/+ and a SOM+/+;ROSA/+ mouse. A: β-galactosidase-
positive cells in the cortex (inset shows higher magnification) of the SOMCRE/+;ROSA/+ mouse 
which serves as a control. B: There was no β-galactosidase-positive cell detected in section 
from the SOM+/+;ROSA/+ mouse. Ctx: Cortex. Scale bar: 250 µm. 
 
3.3. Ablation of glutamate receptor subunits in somatostatin-expressing 
interneurons – preliminary observations 
 
SOMCRE/+ mice were generated to provide a tool to selectively modify gene 
expression in somatostatin-positive interneurons. Somatostatin-expressing 
interneurons in the hippocampus, the so called O-LM cells, are involved in theta 
oscillatory activity and exhibit feedback inhibition on the dendritic compartment of 
principal cells. Since not much is known about the functional properties of different 
glutamate receptors mediating the excitatory input from principal cells onto O-LM 
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cells, the ablation of specific subunits and the functional consequences are an 
interesting starting point. Breeding of SOMCRE/+ mice with both NR12lox mice 
(Shimshek et al., 2006) and GluR-A2lox mice (Zamanillo et al., 1999) were performed 
to obtain knock-out mice lacking these subunits. Electrophysiological analysis was 
performed and the preliminary results are described in the following two paragraphs.  
 
3.3.1. Ablation of the NR1 subunit of NMDAR in somatostatin-positive 
interneurons 
 
SOMCRE/+;NR1-/- mice were generated by breeding SOMCRE/+ mice with NR12lox mice 
that possess loxP sites flanking exons 11-18 of the NR1 gene (Shimshek et al., 
2006). The offspring (F1) were genotyped for both loci and mice positive for CRE 
recombinase and heterozygous for the floxed NR1 gene were further bred with 
NR12lox mice to obtain knock-out mice (F2).  
The first pilot electrophysiological experiments were performed on acute 
hippocampal slices of SOMCRE/+;NR1-/- and control mice (SOM+/+;NR-/-, SOMCRE/+ or 
wild-type) at postnatal day (P) 14. AMPAR and NMDAR currents of O-LM cells of the 
CA1 region of the hippocampus were measured and their ratio was calculated. 
Successful ablation of the NR1 subunit would result in smaller or no NMDAR-
mediated currents in somatostatin-positive cells. 11 O-LM cells from two knock-out 
mice were analysed so far and only one cell was found to lack NMDAR-mediated 
currents. 
 
3.3.2. Ablation of the GluR-A subunit of AMPAR in somatostatin-positive 
interneurons 
 
The ablation of the GluR-A subunit in somatostatin-expressing cells was attempted 
by breeding SOMCRE/+ mice with GluR-A2lox mice that possess loxP sites flanking 
exon 11 of the GluR-A subunit (Zamanillo et al., 1999). The offspring of the F1 
generation were genotyped for the modified somatostatin and for the GluR-A subunit. 
Mice that possessed both modified alleles (SOMCRE/+;GluRA+/-) were subsequently bred 
with GluR-A2lox mice and the resulting knock-outs (F2; SOMCRE/+;GluRA-/-) were further 
analysed by electrophysiological recordings.  
Measurements on acute hippocampal slices of SOMCRE/+;GluRA-/- mice and control 
animals (SOM+/+;GluRA-/-, SOMGluRA-/- or wild-type) at postnatal day (P) 14 were already 
performed. AMPAR- and NMDAR-mediated currents of O-LM cells in the CA1 region 
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of the hippocampus were measured and a reduction or ablation due to the ablation of 
the GluR-A subunit in SOMCRE/+;GA-/- mice was expected. Analysis of O-LM cells of 
one knock-out mouse (n = 4 cells) and one control mouse (n = 5 cells) were 
performed and no change in AMPAR-mediated currents were observed. Evoked 
AMPAR currents of O-LM cells were measured from one SOMCRE/+;GA-/- mouse at P14 
(n = 14 cells) and one SOMCRE/+;GA-/- mouse at P28 (n = 18 cells) but no reduction 
was detected. 
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4. Discussion 
 
GABAergic inhibitory interneurons comprise up to 20% of all neurons in the brain and 
are the counterpart to the larger group of excitatory principal cells (Freund and 
Buzsaki G, 1996). The processing of all afferent and efferent information in the 
mammalian brain is based upon reciprocal action of these two major neuronal 
populations.  
Based on morphological and physiological features, interneurons can be divided into 
several subgroups in contrast to principal cells that are a more homogenous group. 
But regardless of the criteria that were applied to classify these subgroups a clear 
delimitation cannot be made. For instance, interneurons with common anatomical 
features do not necessarily share the same neurochemical or physiological 
characteristics. However, this great variety enables interneurons to exert a huge 
influence on the activity of principal cell populations in the mature brain. One major 
characteristic is the involvement of defined interneuronal subgroups in the generation 
and maintenance synchronous oscillatory network activity. Oscillations occur at 
different frequencies and organise the activity of different groups of principal cells in a 
spatio-temporal manner (Klausberger et al., 2003). Furthermore, different oscillations 
can be associated with distinct behavioural states. GABAergic interneurons also are 
a major source of inhibition in the developing brain influencing numerous 
maturational processes. During embryonic and early postnatal development of the 
brain the excitatory action of GABA influences cell proliferation and acts as a trophic 
factor concerning cell migration and neurite growth (Spoerri PE, 1988).  
Genetic modifications of defined molecular components, such as receptors, of 
GABAergic interneurons help to gain more information about the function of 
interneurons in specific processes such as network activity. An elegant way to 
perform such modifications is to specifically ablate the desired components in defined 
interneuronal populations by utilising the CRE/loxP system (Kwan, 2002;Nagy, 
2000). This system is based on the expression of the site-specific CRE recombinase 
under a cell-type specific promoter. The recombinase catalyses homologous 
recombination at two specific recognition sequences - loxP sites - and thereby 
deletes the fragment in between. In this study two mouse lines with differential cell-
type specific CRE recombinase expression were generated and analysed. In one line 
the CRE recombinase expression is controlled by the GAD67 promoter 
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(GAD67CRE/+). This promoter was chosen, because GAD67 is a common feature of 
GABAergic interneurons and thus the knock-out mice generated by breeding with 
GAD67CRE/+ mice would affect the whole interneuronal population of the brain. In the 
second mouse line, CRE recombinase is under the control of the somatostatin 
promoter (SOMCRE/+) that is present in a specific interneuronal subpopulation. 
Both lines were analysed by breeding the mice with the ROSA26 reporter mice 
(Soriano, 1999) to investigate the functionality of CRE recombinase as well as to 
quantitatively analyse its expression pattern in GAD67- and somatostatin-expressing 
cells by immunohistochemical methods.  
Furthermore, cell-type specific knock-out mice were generated: SOMCRE/+ mice were 
bred with GluR-A2lox mice (Zamanillo et al., 1999) that contain a floxed exon11 of the 
GluR-A subunit of AMPAR as well as with NR12lox mice (Shimshek et al., 2006) that 
possess loxP site flanked exons 11-18 of the NR1 subunit of the NMDAR. Finally, 
some preliminary electrophysiological experiments were performed.  
 
4.1. Generation and analysis of the GAD67CRE/+ mouse line 
 
4.1.1. Generation of GAD67CRE/+ mice by a knock-in approach 
 
The GAD67CRE/+ mouse line was generated by a knock-in approach performed by 
homologous recombination in mouse embryonic stem cells. The targeting construct 
(cloned by Dr. Irinel Coserea, Abbott, Ludwigshafen, Germany) was designed to 
place the CRE recombinase 30 bp upstream of the translational start codon of the 
GAD67 gene. This position was chosen since another previous knock-in approach 
indicated that the insertion into that locus did not affect the promoter activity (Fuchs 
et al., 2001). Based on the expression of a NEO cassette (flanked by frt-sites) that 
was introduced into the targeting construct downstream of the CRE recombinase 
cassette, enabled the selection in ES cells. After blastocyst injection of one correctly 
targeted ES cell clone and germline transmission of the modified GAD67 gene, the 
NEO cassette was removed by breeding GAD67CRE/+;NEO/+ mice with flp-deleter mice 
(Rodriguez et al., 2000) that express the site-specific recombinase flippase. This step 
is necessary since the presence of the NEO cassette can influence the expression of 
the modified gene and thus can lead to a different or false-positive expression pattern 
of CRE recombinase (Fiering et al., 1995). After the removal of the NEO cassette, 
GAD67CRE/+ mice were used for the analysis as well as for backcrossing with C57Bl/6 
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wild-type mice to obtain a common genetic background. Since the embryonic stem 
cells were derived from a different mouse strain (E14.1) up to 10 consecutive 
breedings with C57Bl/6 mice are required to avoid possible influences concerning 
different genetic properties of distinct mouse strains (Joyner A.L., 1993) and 
furthermore to obtain basic standard conditions for future experiments.  
 
4.1.2. Functional analysis of adult GAD67CRE/+ mice 
 
A frequently used approach to validate the functionality of CRE recombinase is to 
breed the CRE recombinase expressing mice with the ROSA26 reporter mice. The 
ROSA26 line was generated by Soriano et al. (Soriano, 1999) and expresses β-
galactosidase upon removal of a loxP-site flanked NEO cassette that can be 
visualised by a X-Gal staining or immunohistochemical experiments. Thus 
GAD67CRE/+ mice were bred with ROSA26 mice and the immunohistochemical 
analysis revealed a β-galactosidase expression pattern resembling the known 
expression pattern of GAD67. These results proved that CRE recombinase was 
functional in vivo and was able to ablate floxed genes of interest. 
To demonstrate that β-galactosidase was indeed expressed in GAD67 containing 
cells, double-labelling experiments were performed. X-Gal staining was combined 
with immunohistochemical staining (DAB method) employing an antibody against 
GAD67. Quantitative analysis of these experiments showed that in the evaluated 
brain areas – motor cortex, somatosensory cortex, striatum and hippocampus – all 
cells expressing the endogenous GAD67 were also labelled for β-galactosidase.  
Around 50% of all analysed cells in adult GAD67CRE/+;ROSA26/+ mice, independent of 
the brain area, were only labelled for β-galactosidase. A possible explanation might 
be the insufficient sensitivity of the GAD67 antibody. Furthermore, the precipitate that 
was formed during the X-Gal staining procedure to detect β-galactosidase might have 
prevented by steric hindrance the binding of the anti-GAD67 antibody.  
Since the detectability of GAD67-positive cells with the used antibody was not 
satisfactory double-labelling experiments were performed with an anti-β-
galactosidase antibody and antibodies against markers for interneuronal 
subpopulations: parvalbumin, calbindin and somatostatin. The results demonstrated 
CRE recombinase expression in almost all neurons of the analysed interneuronal 
subtypes and the number of cells that were only β-galactosidase-positive was 
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comparably low. These results also indicated that the GAD67 antibody used before 
might not label all GAD67-expressing cells. 
However, most likely the presence of β-galactosidase positive cells cannot be 
explained only by the lack of sensitivity of the GAD67 antibody. Early transient 
expression in a subset of cells that later do not have a GABAergic phenotype may be 
in part responsible for the presence of β-galactosidase-positive cells that are GAD67-
negative. 
In GAD67CRE/+;ROSA26/+ mice β-galactosidase is expressed and can be visualised after 
the removal of the stop-cassette by CRE recombinase-mediated homologous 
recombination. An example for transient expression of GAD67 in precursor cells or 
early in development is the presence of β-galactosidase in granule cells of the 
dentate gyrus of the hippocampus (see Fig. 18). These cells are in fact glutamatergic 
but additionally express GABA and thus GAD67 early during development for fine-
tuning of synaptic circuits (Ramirez and Gutierrez, 2001;Sandler R and Smith AD, 
1991;Sloviter RS et al., 1996). Another reason accounting for additional β-
galactosidase staining in granule cells is that pathological stages in the mature brain, 
such as seizure activity, can also induce a switch of a glutamatergic to a GABAergic 
phenotype to compensate the hyperexcitability of principal cells (Gutierrez, 2005). 
 
4.1.3. CRE recombinase is already functional in embryonic GADCRE/+ mice 
 
The X-Gal staining experiments of embryonic GAD67CRE/+;ROSA/+ mice (E16) were 
performed to proof that CRE recombinase recapitulates the temporal and cellular 
expression of GAD67. This is essential to know if GAD67CRE/+ mice are thought to be 
employed in future experiments involving selective gene ablation in GABAergic 
interneurons. Depending on the expression profile of the gene of interest, e.g. a 
developmentally important gene, it is necessary to know when CRE recombinase 
mediated ablation is performed. Immunhistochemical experiments confirmed the 
functionality of CRE recombinase in GAD67CRE/+ embryos. The CRE recombinase 
expression in neuronal tissues, such as the brain (Katarova Z et al., 2000) and the 
spinal cord (Feldblum S. et al., 1995) was in accordance with the GAD67 gene 
expression pattern. Cells in the neocortex and cells invading the hippocampal 
formation that were stained for β-galactosidase were mainly distributed in two layers- 
one in the marginal zone and the cortical plate and one in the intermediate zone and 
the subventricular zone. This pattern was previously shown by fluorescent dye 
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labelling (De Carlos et al., 1996;Lavdas et al., 1999) and by the migration pattern 
analysis in transgenic mice lacking the homeobox genes Distal-less 1 and 2 (DLX-
1/2). In these mice the migration of GABAergic interneurons from the subpallium 
telencephalon to the neocortex was severely affected (Anderson et al., 2001). In 
GAD67-GFP knock-in mice visualisation of GFP-positive cells aided in the 
establishment of these migrational routes and in addition revealed the modes of 
migration of neocortical interneurons (Tanaka et al., 2003;Tamamaki N et al., 
2003;Manent et al., 2006).  
Furthermore, the CRE expression pattern in non-neuronal tissue, like kidney (Liu 
Z.H. et al., 1996) and ectodermal structures, such as vibrissae, limb buds or tailbud 
concurred with the one of the GAD67 gene (Maddox and Condie, 2001). The 
expression of GAD67 in ectodermal non-neuronal tissues points towards a 
participation of GAD67 and GABA in their development. 
 
4.1.4. Reduced GAD67 protein levels in GAD67CRE/+ mice do not have obvious 
developmental or behavioural consequences 
 
Manipulations of the GAD67/GABA system have severe consequences that can be 
seen, for instance, in the loss-of-function mutations of the GAD67 gene. GAD67-/- 
mice die during the first day after birth (P0.5) due to a cleft palate in combination with 
malformations of the respiratory control system in these mice (Asada et al., 
1997;Condie et al., 1997). The GAD activity is reduced to less than 20% in 
homozygous GAD67 knock-out mice compared to wild-type mice and additionally the 
GABA content is reduced to 7 % but no further apparent defects in brain 
morphogenesis were observed (Asada et al., 1997). Experiments in organotypic 
cultures of GAD67 knock-out mice confirmed the preceding results by showing a 
normal development of GABAergic networks and an increase of GABA content due 
to compensatory mechanisms presumably mediated not only by GAD65 but also by 
other factors (Ji et al., 1999;Ji and Obata, 1999). One candidate for such a 
compensating factor is putrescine, a possible precursor for GABA synthesis (De 
Mello FG et al., 1976;Jakoby and Fredericks, 1959;Seiler N. and Al-Therib M.J., 
1974). It was shown that putrescine is present in cells of the developing retina before 
the appearance of GAD expression and is additionally responsible for the GABA 
synthesis (Hokoç JN et al., 1990). Furthermore, in recent work of Sequerra et al. it 
was demonstrated that in the SVZ of the rat, in addition to very low levels of GAD 
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activity, putrescine is a source of GABA synthesis and that it is also produced by 
neuroblasts (Sequerra et al., 2007). It is assumed that the putrescine pathway is 
substituted by the GAD pathway as the organism matures (De Mello FG et al., 1976). 
In addition, it was shown that defects of the cerebral cortex as well as of the 
hippocampus in neurological disorders, such as schizophrenia, bipolar disorder or 
autism, are accompanied by an altered inhibitory GABAergic signalling (Akbarian and 
Huang, 2006). These observations were made on post-mortem brains of subjects 
with neurological disorders. These studies focused on the prefrontal cortex (Akbarian 
S et al., 1995) but also other cortical regions and the hippocampus were analysed 
(Heckers S. et al., 2002). The observed decreased GABA contents in the mentioned 
disorders are due to reduced GAD67 expression levels but not to a loss of specific 
interneuronal subpopulations.  
Despite of the apparent and expected normal development of GAD67CRE/+ mice (e.g. 
normal body weight and breeding behaviour) possible subtle deficits resulting from 
the knock-in of CRE recombinase in one GAD67 allele had to be investigated. 
Therefore, preliminary behavioural tests with a pilot group of knock-in and wild-type 
mice were performed. The results indicated that the tested GAD67CRE/+ mice did not 
show impairments in their explorative behaviour and furthermore their motor learning 
ability seemed to be normal. To draw final conclusions concerning the behaviour of 
GADCRE/+ mice the number of tested individuals must be increased to gain statistical 
validity. Subsequently to the behavioural analysis, the GAD67 protein levels in these 
mice were checked by Western blot analysis. As expected from the previously 
mentioned results of the GAD67 knock-out mice (Asada et al., 1997;Condie et al., 
1997), the Western blot analysis revealed a decrease of around 50% concerning the 
GAD67 protein level in GADCRE/+ mice compared to their wild-type littermates. 
 
4.1.5. Future plans: Ablation of the trkB receptor in all GABAergic interneurons  
 
A factor that is involved in activity-dependent maturation of interneurons is the brain-
derived neurotrophic factor (BDNF) (Marty et al., 1997;Thoenen, 1995). BDNF 
belongs to the family of neurotrophins, together with neurotrophin-3 and 
neurotrophin-4/5, and is expressed exclusively by principal cells (Altar C.A. et al., 
1994). Its receptor is the trKB receptor tyrosine kinase (Klein R. et al., 1989) that is 
expressed only by interneurons (Zachrisson et al., 1996) and mediates its effects via 
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the phospholipase Cγ- pathway (Widmer H.R. et al., 1993;Huang and Reichardt, 
2003). 
The ablation of trkB signalling in trkB-null mice (Klein R. et al., 1993;Widmer H.R. et 
al., 1993) demonstrated reduced migration of interneurons in the developing 
neocortex and hippocampus and confirmed the role of BDNF in interneuronal 
migration (Polleux et al., 2002). It was also shown that BDNF is able to promote 
dendritic growth of neocortical interneurons in organotypic slice cultures (Jin et al., 
2003). Furthermore, BDNF regulates synaptogenesis that was demonstrated in vitro 
in cell culture (Rutherford et al., 1997;Vicario-Abejon et al., 1998) as well as in vivo in 
mice overexpressing BDNF postnatally in the visual cortex (Huang et al., 1999).  
Developmental functions of the BDNF/trkB signalling and its influence on network 
activity will be further analysed in mice with ablated trkB receptors in all GABAergic 
interneurons. To this end GAD67CRE/+ mice are currently being bred with trkBlox/lox 
mice (Minichiello et al., 1999).  
In addition, GAD67CRE/+;trkB-/- knock-out mice could also be utilised to focus on the 
involvement of GABAergic interneurons in specific cognitive disorders, such as 
schizophrenia. Several studies indicate that interneurons play a central role in the 
pathogenesis of these diseases and might explain a number of the disease 
characteristics (Akbarian S et al., 1995). Reduction of expression level of the trkB 
receptor, for instance, is reflected in reduced GAD67 mRNA expression in 
GABAergic interneurons that can also be detected in subjects with schizophrenia 
(Akbarian and Huang, 2006). Furthermore, it was shown that in the trkB knock-out 
mice parvalbumin-expressing interneurons are specifically affected and exhibit a 
decrease in parvalbumin and GAD67 expression that is directly correlated to the 
decrease of trkB gene expression (Hashimoto et al., 2005). A reduction in the activity 
of parvalbumin-expressing interneurons has been correlated with a reduction in 
gamma oscillations as well as with impaired working memory as demonstrated in a 
recent study (Fuchs et al., 2007). These findings show similarities with certain clinical 
features exhibited by patients with schizophrenia. Patients have an impaired onset of 
gamma activity in response to a stimulus and presumably, as a consequence of that, 
show deficits in working memory (Spencer et al., 2003).  
Since the above-mentioned studies were performed in mice with incomplete ablation 
of the trkB receptor, the ablation of the trkB receptor in all GAD67-expressing 
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interneurons with GAD67CRE/+ mice could open up new possibilities to investigate the 
underlying mechanisms of cognitive disorders.  
 
4.2. Generation and analysis of the SOMCRE/+ mouse line 
 
4.2.1. Generation of SOMCRE/+ mice via a knock-in approach 
 
The generation of a mice expressing CRE recombinase under the control of an 
interneuronal subtype-specific promoter was performed by a knock-in approach. 
SOMCRE/+ mice were generated by gene targeting in R1 mouse embryonic stem cells 
(Nagy et al., 1993). The targeting cassette consisting of CRE recombinase followed 
by a NEO cassette, flanked by frt-sites, was inserted right after the translational start 
codon of the somatostatin gene via homologous recombination in mouse ES cells. In 
contrast to the generation of the GAD67CRE/+ mice, where the CRE recombinase was 
inserted upstream of the ATG (since previous experiments were successful using this 
approach) (Fuchs et al., 2001), CRE recombinase in the SOMCRE/+  mice was 
inserted after the ATG. This should prevent a negative effect on the promoter activity 
by the insertion of CRE recombinase.  
Following blastocyst injection of a positive ES clone and successful germline 
transmission of the targeted somatostatin gene, the NEO cassette was removed by 
breeding the mice with flp-deleter mice (Rodriguez et al., 2000). The NEO cassette 
that was used for negative selection in ES cell culture can severely influence the 
expression of the modified gene and lead to an incomplete or to a false-positive 
expression pattern (Fiering et al., 1995). SOMCRE/+ mice without NEO cassette were 
further backcrossed to the genetic background of the C57Bl/6 strain. This is required 
since the used ES cells were derived from another mouse strain (R1, (Nagy et al., 
1993)) and a common genetic background is needed as a basis for further 
experiments. SOMCRE/+ mice inherited the targeted gene according to the Mendelian 
ratio, furthermore they did not show any obvious anatomical, behavioural or 
physiological defects. Therefore one can assume that the missing somatostatin 
expression of the targeted allele in the heterozygous knock-in mice is compensated 
by specific mechanisms. This was expected since already the complete knock-out of 
the somatostatin gene demonstrated no severe deficits in their development 
(Buckmaster PS et al., 2002;Low et al., 2001). One of the compensating mechanisms 
for the lack of somatostatin expression in the knock-out mice was shown to be an 
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upregulation of the somatostatin receptors (Ramirez et al., 2002;Videau et al., 2003). 
This especially applies for the somatostatin receptor 2 (sst2) that exhibited a 
significantly increased expression level in somatostatin knock-out mice (Cammalleri 
et al., 2006). Furthermore, it was concluded that somatostatin is actively participating 
in the regulation of its receptors, especially sst2 (Csaba et al., 2004). Another 
compensating mechanism could be mediated by the related neuropeptide cortistatin 
that shares 11 of 14 aminoacid residues with somatostatin-14 and, additionally, binds 
in vitro with a similar affinity like somatostatin to the five somatostatin receptors (de 
Lecea et al., 1996). Cammalleri et al. could showed that the cortistatin expression 
level was 60% higher in somatostatin knock-out compared to wild-type mice 
(Cammalleri et al., 2006). 
Possible changes in the protein levels of somatostatin in SOMCRE/+ mice compared to 
wild-type littermates could not be determined since antibodies against somatostatin 
for its detection in Western blot analysis are not commercially available. 
 
4.2.2. Analysis of the functionality of CRE recombinase in adult SOMCRE/+ 
mouse brains 
 
Crossing of SOMCRE/+ mice with ROSA26 reporter mice (Soriano, 1999) was used on 
the one hand to proof the functionality of CRE recombinase in vivo, and on the other 
hand to analyse its expression pattern and the correspondence with that of the 
endogenous somatostatin gene. ROSA26 mice contain a floxed NEO cassette in the 
ROSA26 locus whose presence suppresses the transcription of a β-galactosidase 
gene. Upon CRE recombinase mediated ablation of the floxed NEO cassette β-
galactosidase is expressed and can be visualised with distinct immunohistochemical 
staining methods.  
The immunohistochemical staining experiments for β-galactosidase proofed the in 
vivo functionality of CRE recombinase and the expression pattern indicated that its 
expressed in somatostatin-positive interneurons. But the quantitative analysis that 
was performed by double-labelling experiments for β-galactosidase and the 
endogenous somatostatin revealed that CRE recombinase is not expressed in all 
somatostatin-positive cells. The percentage of double-positive cells lies between 25 
and 60% depending on the analysed brain region. The highest amount of double-
labelled cells can be found in the CA1 area of the hippocampus (60.2%) followed by 
the striatum (52.7%). Since this mouse line was generated by a knock-in approach 
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that should guarantee a targeted allele in every somatostatin-expressing cell, the 
reason for this incomplete CRE recombinase expression is not clear. One 
explanation could be related to the complex promoter region of the somatostatin 
gene. It consists of a proximal cAMP response element (CRE) (Montminy et al., 
1986), a tripartite regulatory domain consisting of an upstream enhancer (SMS-UE) 
and two neighbouring tissue-specific enhancers (TSEI and II), as well as silencer 
elements (PS1, PS2) (Vallejo et al., 1992a;Vallejo et al., 1992b;Vallejo et al., 1995). 
Dynamic and complex interactions between these promoter elements and its factors, 
such as transcriptional activator and repressor proteins, allows cell-specific 
expression of somatostatin that is expressed in neuronal as well as non-neuronal 
tissues of different developmental origin. CRE, for instance, positively regulates the 
basal expression level of somatostatin in neurons (Schwartz and Vallejo, 1998). 
Whereas the SMS-UE region represents a D-cell-specific enhancer and is thus 
responsible for somatostatin expression in pancreatic cells and is furthermore 
negatively regulated during development by at least one of the two proximal silencer 
(PS) elements (Vallejo et al., 1992a;Vallejo et al., 1992b). The multi-layered 
organisation of the somatostatin gene expression makes it also more sensitive 
towards genetic manipulations. The introduction of CRE recombinase by homologous 
recombination might have caused minor structural changes in the sequence of the 
promoter region and thereby affected the responsible elements for somatostatin 
expression in neurons so that in some neurons CRE recombinase cannot be 
transcribed. Alternatively, the expression level of CRE recombinase in these cells is 
so low due to modifications of enhancer or repressor elements that either site-
specific recombination cannot be performed or be detected by immunhistochemical 
methods. 
The missing CRE recombinase expression has also an advantage. Future planned 
experiments with SOMCRE/+ mice are mainly focused on the hippocampus and 
especially the CA1 region. This region shows the highest amount of co-expression 
and therefore has the highest probability of specifically modified cells. Furthermore, 
the cell-type specific ablation of genes is always present in the whole brain. The 
resulting influences derived from other brain regions than the analysed one have 
normally to be taken into account while evaluating an experiment. But these 
influences will be diminished in the SOMCRE/+ mice due to the CRE expression 
pattern. 
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The number of cells that are only positive for β-galactosidase is highest in the CA3 
and CA1 region of the hippocampus (10-16%) and rather low in the other areas (up 
to 2.9%; see also Tab. 3). These percentages coincide with the development of 
somatostatin-containing neurons in the hippocampus as well as the cortical regions. 
This developmental process includes transient expression of the somatostatin gene. 
Therefore a number of only β-galactosidase-positive cells are detected in adult 
SOMCRE/+;ROSA/+ mouse brains since CRE recombinase is expressed as soon as its 
controlling promoter is active and then CRE recombinase is able to mediate site-
specific recombination throughout life. It was shown by many studies in rat 
(Burgunder J.-M., 1994;Naus C.C.G. et al., 1988a;Naus C.C.G. et al., 
1988b;Shiosaka S et al., 1982) and mouse (Bendotti C. et al., 1990;Forloni G. et al., 
1990) that somatostatin is highly expressed during the first two to three postnatal 
weeks and afterwards decreases to the lower adult expression level. During the 
development of the hippocampus high somatostatin expression can be detected in 
the whole stratum oriens and the hilus, that is in accordance with the number of cells 
only expressing β-galactosidase and not somatostatin in the CA1 and CA3 region of 
the hippocampus of SOMCRE/+;ROSA/+ mice. This is also valid for the β-galactosidase-
positive cells in other regions since a decrease of somatostatin expression during 
development was also shown for other brain regions, such as the cerebral cortex. 
The only difference is that the decline of expression in these areas is not as striking 
as in the hippocampus. Another example for a brain area where transient 
somatostatin expression occurs and was detected during analysis of the 
SOMCRE/+;ROSA/+ mice is the lateral septum (Bendotti C. et al., 1990;Shiosaka S et al., 
1982). 
The temporary distinct expression profile of the somatostatin gene might also explain 
the few β-galactosidase expressing cells in the pyramidal cell layer of the 
hippocampus that are not of GABAergic origin. Possibly, the somatostatin promoter 
is active in a small subset of principal cells during development. The fact that CRE 
recombinase is active in few pyramidal cells has to be kept in mind since CRE 
recombinase is able to promote site-specific recombination of floxed genes of interest 
also in these cells. This misexpression might have an influence on results in 
experiments performed with cell-type specific knock-out mice generated with the 
SOMCRE/+ line. 
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4.2.3. CRE recombinase is already functional in embryonic SOMCRE/+ mice 
 
The analysis of CRE recombinase expression in embryonic SOMCRE/+ mice was 
performed by breeding SOMCRE/+ mice with mice of the ROSA26 reporter line 
(Soriano, 1999). X-Gal staining experiments of SOMCRE/+;ROSA/+ mouse embryos at 
embryonic day (E) 15 showed that CRE recombinase is already expressed in 
neuronal as well as non-neuronal tissues. This corresponds with previous studies on 
the developmental expression of somatostatin by in situ hybridisation and 
immunohistochemical experiments (Bendotti C. et al., 1990;Burgunder J.-M., 
1994;Shiosaka S et al., 1982;Soriano, 1999). The expression of β-galactosidase in 
the central nervous system of E15 SOMCRE/+;ROSA26/+ mice is rather low, since an 
increase of somatostatin expression and thus the promoter activity, primarily appears 
after birth during the first three weeks of postnatal life (Bendotti C. et al., 1990;Forloni 
G. et al., 1990). The detected ‘expression gradient’, with a higher β-galactosidase 
expression level in the thalamic region and a lower one in the neocortex was 
described by J.-M. Burgunder in the rat (at a comparable age) (Burgunder J.-M., 
1994). The β-galactosidase-labelling of somatostatin-positive cells in the spinal cord 
with a more dominant staining of the ventral horn corresponds with previous studies 
in the prenatal rat (Senba E et al., 1982). It indicates that somatostatin is involved in 
the development of the spinal cord since the expression in the ventral horn 
decreases remarkably after birth and the moderate levels in the dorsal horn remain 
also in the adult. CRE recombinase activity in the developing cerebellum, as well as 
in the dorsal root ganglia and the trigeminal ganglion is consistent with somatostatin 
expression in these tissues found by other research groups (Naus, 1990;Ichikawa et 
al., 2003;Baxter and Smith, 1998). 
The expression of CRE recombinase in non-neuronal tissue can also be confirmed 
by previous observations, such as expression in the guts (Gittes and Rutter, 1992), 
the kidney (Bates et al., 2004) and the adrenal gland (Maurer and Reubi, 1986). 
Taken together these results demonstrate that cell-type specific ablation of genes of 
interest by CRE recombinase mediated site-specific recombination can already be 
performed in the developing nervous system of the SOMCRE/+ mouse. Hence also 
developmental questions pertaining to the functional role of somatostatin-expressing 
interneurons can be approached.  
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4.3. Ablation of AMPAR and NMDAR subunits in somatostatin-
positive interneurons: Preliminary results 
 
Interneurons exhibit a great influence on network activity by shaping the output of 
principal cells via inhibition. Interneurons are recruited by the activation of fast 
ionotropic glutamate receptors, of the AMPA- and NMDA-type. 
The use of genetically modified mice with glutamate receptor subunit ablations was 
helpful in gaining more insight into their function. The global knock-out of the NR1 
subunit, for instance, first revealed the importance of the NMDAR in prenatal 
development since the mutant mice died within the first 8-15 hours after birth (Li et 
al., 1994). The life span was dependent on the level of the transgene expression and 
thus it could be shown that NMDAR play a crucial role in formation of sensory-related 
neural patterns (Iwasato et al., 1997;Li et al., 1994). Cell-type specific ablation of the 
NR1 subunit in the CA1 region, furthermore, showed impaired hippocampal space 
representation due to the lack of NMDAR-mediated synaptic plasticity (McHugh et 
al., 1996;Tsien et al., 1996).  
Complete ablation of the GluR-A subunit leads to a reduction of the amount of 
AMPAR in the CA1 region of the hippocampus associated with a loss of long-term 
potentiation at CA3 to CA1 synapses (Zamanillo et al., 1999). In another study, the 
GluR-A subunit was ablated selectively in fast-spiking parvalbumin-expressing 
interneurons and revealed reduced excitation of parvalbumin-positive interneurons 
and as a consequence disrupted hippocampal gamma oscillations in vitro (Fuchs et 
al., 2007). On a behavioural level the animals showed impairment of hippocampus-
dependent working memory and of short-term recognition memory. Parvalbumin-
expressing interneurons comprise a large number of hippocampal interneurons and it 
was obvious to analyse their role in hippocampal network activity and the behavioural 
consequences. In contrast, not much is known about the functional properties of 
hippocampal somatostatin-expressing interneurons, especially O-LM cells that are 
thought to be involved in the generation of theta oscillation by exhibiting feedback 
inhibition on principal cells (Lacaille et al., 1987). Hence, it would be interesting to 
investigate the consequences of changed excitatory input on O-LM cells by genetic 
manipulations. Therefore ongoing work includes the cell-type specific ablation of the 
NR1 subunit of NMDR as well as the GluR-A subunit of AMPAR in somatostatin-
positive cells using SOMCRE/+ mice. First preliminary electrophysiological results will 
now be shortly discussed. 
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4.3.1. Ablation of the NR1 subunit of the NMDAR in somatostatin-positive cells 
 
Breedings of SOMCRE/+ mice with NR12lox mice (Shimshek et al., 2006) are currently 
in progress and one SOMCRE/+;NR1-/- and two control mice (age: P14) were analysed 
by electrophysiological experiments so far. Out of four measured cells, one showed a 
reduced NMDAR-mediated current. This preliminary result, of course, has no 
statistical validity but it indicates that the ablation of the NR1 subunit in O-LM cells 
mediated by CRE recombinase site-specific recombination is functional. Additionally, 
it has to be taken into account that not all somatostatin-expressing in the stratum 
oriens of the CA1 region, where the measurements were performed, are also 
expressing CRE recombinase. However, further experiments will clarify whether this 
cell-type specific knock-out approach can help to gain more insight into the role of 
NMDAR in O-LM cells and theta oscillatory activity in the hippocampus. 
 
4.3.2. Ablation of the GluR-A subunit in interneurons expressing somatostatin 
 
Mice with cell-type specific ablation of the GluR-A subunit in somatostatin-positive 
interneurons were generated by breeding SOMCRE/+ with GluRA2lox mice (Zamanillo et 
al., 1999). Until now one SOMCRE/+;GluRA-/- and one control mouse (P14) were 
subjected to electrophysiological analysis. No reduction of AMPAR-mediated 
currents were detected. To exclude that CRE recombinase mediated site-specific 
recombination of the floxed GluR-A subunit takes longer than two weeks, 
electrophysiological measurements were performed on P28 SOMCRE/+;GluRA-/- animals. 
Again no altered AMPAR currents were measured. Since the functionality of the 
ablation of the GluR-A subunit was demonstrated in previous studies (Fuchs et al., 
2007;Zamanillo et al., 1999), the lack of alterations in the AMPAR currents cannot be 
explained by problems regarding recombination in the GluRA2lox mice. In addition, the 
analysis of SOMCRE/+ mice showed that the CRE recombinase was able to promote 
site-specific recombination already at embryonic stages. Hence, one has to consider 
other reasons and compensatory mechanism as a possibility for the lack of effect 
regarding the measured AMPAR currents. Thus it is conceivable that GluR-A 
expression in O-LM cells is normally low and does not contribute to AMPAR 
mediated currents. Since not much is known about expression of AMPAR subunits in 
O-LM cells further analysis have to be performed to establish AMPAR subunit 
composition in this cell population.  
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5. Abbreviations 
 
%   Percentage 
α   Alpha 
β   Beta 
γ   Gamma 
[α35S]dATP  Adenosine triphosphate labeled with 35S in gamma position 
α32P-dCTP  Deoxicytosin triphosphate labeled with 32P in alpha position 
µ   Micro 
A    Ampere 
AMPA   L-α-amino-3-hydroxy-5-methyl-4-isoxazolpropionic acid 
AMPAR  AMPA receptor 
ATP   Adenosine triphosphate 
BAC   Bacterial artificial chromosome 
BDNF   Brain-derived neurotrophic factor 
bp   Base pairs 
BSA   Bovine serum albumin 
C   Celcius 
CA1 - 3  Cornus ammonis fields 1 - 3 
cAMP   Cyclic adenosine monophosphate 
CRE   cAMP-responsive element 
CRE   CRE recombinase 
Da   Dalton 
DAB   Diaminobenzidine 
DEPC   Diethyl pyrocarbonate 
DNA   Deoxyribonucleic acid 
dNTPs  Deoxyribonucleotides 
DTT   Dithiothreitol 
E   Embryonic day 
E.coli   Escherichia coli 
EDTA   Ethylene diaminetetraacetic acid 
EPSC   Excitatory postsynaptic potential 
ES   Embryonic stem cells 
et al.   et alii 
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Fig.   Figure 
Flp   Flp recombinase 
G418   Geniticin 
GABA   γ-Aminobutyric acid 
GAD   Glutamic acid decarboxylase 
GluR   Glutamate receptor 
h   hour 
HEPES  N-(2-Hydroxyethyl)piperazine-N’-ethanesulfonic acid 
Hz   Hertz 
IgG   Immunoglobuline G 
ISH   In situ hybridisation 
kB   Kilobase 
kDa   Kilodalton 
lacZ   β-galactosidase 
LIF   Leukaemia Inhibitory Factor 
loxP   Locus of crossing over (for) phage P 
LTP   Long-term potentiation 
m   Milli 
M   Mol 
mGluR  Metabotropic glutamate receptor 
min   Minute 
mRNA  messenger RNA 
n   Number 
NEO   Neomycin resistance gene 
NMDA  N-methyl-D-aspartate 
NMDAR  NMDA receptor 
NR1   NMDAR subunit 1 
P   Postnatal day 
PBS   Phosphate buffered saline 
PCR   Polymerase chain reaction 
PFA   Paraformaldehyde 
PKC   Protein kinase C 
RNA   Ribonucleid acid 
RT   Room temperature 
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s   Second 
SDS   Sodium dodecylsulfate 
SDS-PAGE  SDS-Polyacrylamide Gel Electrophoresis 
SEM   Standard error of the mean 
STDEV  Standard deviation 
t   Time 
Taq   Therminus aquaticus 
TE   TRIS/EDTA buffer 
TENS   Tris-EDTA-sodium chloride-SDS buffer 
TRIS   Tris(hydroxymethyl)aminomethan 
TRIS-HCl  Tris(hydroxymethyl)aminomethan-hydrochloride 
U   Unit 
V   Voltage 
V   Volts 
W   Watt 
wt   wildtype 
X-Gal   5-brom-4-chlor-3-indolyl-b-D-galactopyranoside 
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